<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName archivearticle3.dtd?><?SourceDTD.Version 3.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Brain Behav</journal-id><journal-id journal-id-type="iso-abbrev">Brain Behav</journal-id><journal-id journal-id-type="doi">10.1002/(ISSN)2157-9032</journal-id><journal-id journal-id-type="publisher-id">BRB3</journal-id><journal-title-group><journal-title>Brain and Behavior</journal-title></journal-title-group><issn pub-type="epub">2162-3279</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5840452</article-id><article-id pub-id-type="doi">10.1002/brb3.936</article-id><article-id pub-id-type="publisher-id">BRB3936</article-id><article-categories><subj-group subj-group-type="overline"><subject>Original Research</subject></subj-group><subj-group subj-group-type="heading"><subject>Original Research</subject></subj-group></article-categories><title-group><article-title>Serum vitamin D in patients with mild cognitive impairment and Alzheimer's disease</article-title><alt-title alt-title-type="left-running-head">SHINJI et&#x000a0;al.</alt-title></title-group><contrib-group><contrib id="brb3936-cr-0001" contrib-type="author"><name><surname>Ouma</surname><given-names>Shinji</given-names></name><xref ref-type="aff" rid="brb3936-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="brb3936-cr-0002" contrib-type="author"><name><surname>Suenaga</surname><given-names>Midori</given-names></name><xref ref-type="aff" rid="brb3936-aff-0002">
<sup>2</sup>
</xref></contrib><contrib id="brb3936-cr-0003" contrib-type="author"><name><surname>B&#x000f6;l&#x000fc;kba&#x0015f;&#x00131; Hatip</surname><given-names>Funda F.</given-names></name><xref ref-type="aff" rid="brb3936-aff-0003">
<sup>3</sup>
</xref></contrib><contrib id="brb3936-cr-0004" contrib-type="author"><name><surname>Hatip&#x02010;Al&#x02010;Khatib</surname><given-names>Izzettin</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9127-6779</contrib-id><xref ref-type="aff" rid="brb3936-aff-0003">
<sup>3</sup>
</xref></contrib><contrib id="brb3936-cr-0005" contrib-type="author"><name><surname>Tsuboi</surname><given-names>Yoshio</given-names></name><xref ref-type="aff" rid="brb3936-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="brb3936-cr-0006" contrib-type="author" corresp="yes"><name><surname>Matsunaga</surname><given-names>Yoichi</given-names></name><address><email>matsunaga@ph.bunri-u.ac.jp</email></address><xref ref-type="aff" rid="brb3936-aff-0002">
<sup>2</sup>
</xref></contrib></contrib-group><aff id="brb3936-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">Department of Neurology</named-content>
<named-content content-type="organisation-division">Faculty of Medicine</named-content>
<institution>Fukuoka University</institution>
<named-content content-type="city">Fukuoka</named-content>
<country country="JP">Japan</country>
</aff><aff id="brb3936-aff-0002">
<label><sup>2</sup></label>
<named-content content-type="organisation-division">Department of Medical Pharmacology</named-content>
<named-content content-type="organisation-division">Faculty of Pharmaceutical Sciences</named-content>
<institution>Tokushima Bunri University</institution>
<named-content content-type="city">Tokushima</named-content>
<country country="JP">Japan</country>
</aff><aff id="brb3936-aff-0003">
<label><sup>3</sup></label>
<named-content content-type="organisation-division">Department of Medical Pharmacology</named-content>
<named-content content-type="organisation-division">Faculty of Medicine</named-content>
<institution>Pamukkale University</institution>
<named-content content-type="city">Denizli</named-content>
<country country="TR">Turkey</country>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break/>
Yoichi Matsunaga, Department of Medical Pharmacology, Faculty of Pharmaceutical Sciences, Tokushima Bunri University, Tokushima, Japan.<break/>
Email: <email>matsunaga@ph.bunri-u.ac.jp</email><break/></corresp></author-notes><pub-date pub-type="epub"><day>09</day><month>2</month><year>2018</year></pub-date><pub-date pub-type="collection"><month>3</month><year>2018</year></pub-date><volume>8</volume><issue>3</issue><issue-id pub-id-type="doi">10.1002/brb3.2018.8.issue-3</issue-id><elocation-id>e00936</elocation-id><history><date date-type="received"><day>24</day><month>6</month><year>2017</year></date><date date-type="rev-recd"><day>02</day><month>12</month><year>2017</year></date><date date-type="accepted"><day>10</day><month>1</month><year>2018</year></date></history><permissions><!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2018 Published by Wiley Periodicals, Inc. <copyright-statement>--><copyright-statement content-type="article-copyright">&#x000a9; 2018 The Authors. <italic>Brain and Behavior</italic> published by Wiley Periodicals, Inc.</copyright-statement><license license-type="creativeCommonsBy"><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:type="simple" xlink:href="file:BRB3-8-e00936.pdf"/><abstract id="brb3936-abs-0001"><title>Abstract</title><sec id="brb3936-sec-0001"><title>Objectives</title><p>To determine the relevance of Mini&#x02010;Mental State Examination (<styled-content style="fixed-case">MMSE</styled-content>), serum 25&#x02010;hydroxyvitamin D (25(<styled-content style="fixed-case">OH</styled-content>)D3), and 1,25(<styled-content style="fixed-case">OH</styled-content>)2D3 concentrations to mild cognitive impairment (<styled-content style="fixed-case">MCI</styled-content>) and various stages of Alzheimer's disease (<styled-content style="fixed-case">AD</styled-content>).</p></sec><sec id="brb3936-sec-0002"><title>Materials and Methods</title><p>The study included 230 participants (&#x0003e;74&#x000a0;years) allocated to three main groups: 1&#x02010;healthy subjects (<styled-content style="fixed-case">HS</styled-content>,<italic> n</italic>&#x000a0;=&#x000a0;61), 2&#x02010;patients with <styled-content style="fixed-case">MCI</styled-content> (<italic>n</italic>&#x000a0;=&#x000a0;61), and 3&#x02010; patients with Alzheimer's disease (<styled-content style="fixed-case">AD</styled-content>) subdivided into three stages: mild (<italic>n</italic>&#x000a0;=&#x000a0;41), moderate (<italic>n</italic>&#x000a0;=&#x000a0;35), and severe <styled-content style="fixed-case">AD</styled-content> (<italic>n</italic>&#x000a0;=&#x000a0;32). The cognitive status was evaluated using <styled-content style="fixed-case">MMSE</styled-content>. Serum 25 (<styled-content style="fixed-case">OH</styled-content>)D3 (ng/ml) and 1,25(<styled-content style="fixed-case">OH</styled-content>)2D3 concentrations (pg/ml) were determined by competitive radioimmunoassay.</p></sec><sec id="brb3936-sec-0003"><title>Results</title><p>
<styled-content style="fixed-case">MMSE</styled-content> scores and 25(<styled-content style="fixed-case">OH</styled-content>)D3 were decreased in <styled-content style="fixed-case">MCI</styled-content> and all stages of the <styled-content style="fixed-case">AD</styled-content> in both genders. <styled-content style="fixed-case">MMSE</styled-content> variability was due to gender in <styled-content style="fixed-case">HS</styled-content> (11%) and to 25(<styled-content style="fixed-case">OH</styled-content>)D3 in <styled-content style="fixed-case">MCI</styled-content> (15%) and <styled-content style="fixed-case">AD</styled-content> (26%). <styled-content style="fixed-case">ROC</styled-content> analysis revealed an outstanding property of <styled-content style="fixed-case">MMSE</styled-content> in diagnosis of <styled-content style="fixed-case">MCI</styled-content> (<styled-content style="fixed-case">AUC</styled-content>, 0.906; <styled-content style="fixed-case">CI</styled-content> 95%, 0.847&#x02013;0.965; sensitivity 82%; specificity, 98%) and <styled-content style="fixed-case">AD</styled-content> (<styled-content style="fixed-case">AUC</styled-content>, 0.997; <styled-content style="fixed-case">CI</styled-content> 95%, 0.992&#x02013;1; sensitivity, 100%; specificity, 98%). 25(<styled-content style="fixed-case">OH</styled-content>)D3 exhibited good property in <styled-content style="fixed-case">MCI</styled-content> (<styled-content style="fixed-case">AUC</styled-content>, 0.765; <styled-content style="fixed-case">CI</styled-content> 95%, 0.681&#x02013;0.849; sensitivity, 90%; specificity, 54%) and an excellent property in diagnosis of <styled-content style="fixed-case">AD</styled-content> (<styled-content style="fixed-case">AUC</styled-content>, 0.843; <styled-content style="fixed-case">CI</styled-content> 95%, 0.782&#x02013;0.904; sensitivity, 97%; specificity, 79%). Logistic analyses revealed that, in <styled-content style="fixed-case">MCI</styled-content>,<styled-content style="fixed-case"> MMSE</styled-content> could predict (or classify correctly) with 97.6% accuracy (Wald, 15.22, &#x003b2;, &#x02212;0.162; <italic>SE</italic>, 0.554; <styled-content style="fixed-case">OR</styled-content>&#x000a0;=&#x000a0;0.115:0.039&#x02013;0.341; <italic>p</italic>&#x000a0;=&#x000a0;.0001), whereas 25(<styled-content style="fixed-case">OH</styled-content>)D3 with 80% accuracy (Wald, 41,013; &#x003b2;, &#x02212;0.213; <italic>SE</italic>, 0.033; <styled-content style="fixed-case">OR</styled-content>&#x000a0;=&#x000a0;0.808: 0.757&#x02013;863; <italic>p</italic>&#x000a0;=&#x000a0;.0001). 25(<styled-content style="fixed-case">OH</styled-content>)D3 was the only significant predictor for the severe <styled-content style="fixed-case">AD</styled-content> and contributed to <styled-content style="fixed-case">MMSE</styled-content> variability. Age and gender were significant predictors only in the moderate <styled-content style="fixed-case">AD</styled-content>. In patients with <styled-content style="fixed-case">MCI</styled-content>, 25(<styled-content style="fixed-case">OH</styled-content>)D3 and 1,25(<styled-content style="fixed-case">OH</styled-content>)2D3 were correlated men, but in case of the <styled-content style="fixed-case">AD</styled-content>, they were correlated in women.</p></sec><sec id="brb3936-sec-0004"><title>Conclusions</title><p>
<styled-content style="fixed-case">MMSE</styled-content> and serum 25(<styled-content style="fixed-case">OH</styled-content>)D3 concentrations could be useful biomarkers for prediction and diagnosis of <styled-content style="fixed-case">MCI</styled-content> and various stages of the <styled-content style="fixed-case">AD</styled-content>. The results support the utility of vitamin D supplementation in <styled-content style="fixed-case">AD</styled-content> therapy regimen.</p></sec></abstract><kwd-group kwd-group-type="author-generated"><kwd id="brb3936-kwd-0001">1,25(<styled-content style="fixed-case">OH</styled-content>)<sub>2</sub>D<sub>3</sub></kwd><kwd id="brb3936-kwd-0002">25(<styled-content style="fixed-case">OH</styled-content>)D<sub>3</sub></kwd><kwd id="brb3936-kwd-0003">Alzheimer's disease</kwd><kwd id="brb3936-kwd-0004">mild cognitive impairment</kwd><kwd id="brb3936-kwd-0005">mini&#x02010;mental state examination</kwd></kwd-group><funding-group><award-group><funding-source>Ministry of Education, Science, Sport and Culture of Japan</funding-source><award-id>15K08631</award-id></award-group></funding-group><counts><fig-count count="4"/><table-count count="4"/><page-count count="12"/><word-count count="9908"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>component-id</meta-name><meta-value>brb3936</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>March 2018</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:version=5.3.2.2 mode:remove_FC converted:07.03.2018</meta-value></custom-meta></custom-meta-group></article-meta><notes><p content-type="self-citation">
<mixed-citation publication-type="journal" id="brb3936-cit-1001">
<string-name>
<surname>Ouma</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Suenaga</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>B&#x000f6;l&#x000fc;kba&#x0015f;&#x00131; Hatip</surname>
<given-names>FF</given-names>
</string-name>, <string-name>
<surname>Hatip&#x02010;Al&#x02010;Khatib</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Tsuboi</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Matsunaga</surname>
<given-names>Y</given-names>
</string-name>. <article-title>Serum vitamin D in patients with mild cognitive impairment and Alzheimer's disease</article-title>. <source>Brain Behav</source>. <year>2018</year>;<volume>8</volume>:<elocation-id>e00936</elocation-id>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/brb3.936">https://doi.org/10.1002/brb3.936</ext-link>
</mixed-citation>
</p></notes></front><body><sec id="brb3936-sec-0005"><label>1</label><title>INTRODUCTION</title><p>Alzheimer's disease (AD) is the most common cause of cognition impairment in elderly populations. AD is characterized by dementia with progressive loss of memory, intellectuality, disturbance of language ability, impairment in social performance, and reduced independence (i.e., the need for caregiver support in daily life). Although a definitive diagnosis of AD can only be made based on histopathological examination of brain specimens, the clinical diagnosis of AD could have a high degree of accuracy if dementia is diagnosed using a cognitive score (Creavin et&#x000a0;al., <xref rid="brb3936-bib-0015" ref-type="ref">2016</xref>; Votruba, Persad, &#x00026; Giordani, <xref rid="brb3936-bib-0052" ref-type="ref">2016</xref>). In addition to age and gender, the Mini&#x02010;Mental State Examination (MMSE) has been regarded as a useful instrument for evaluating the cognitive state of patients (Folstein, Folstein, &#x00026; McHugh, <xref rid="brb3936-bib-0025" ref-type="ref">1975</xref>) and used as a predictor of AD (Musicco et&#x000a0;al., <xref rid="brb3936-bib-0040" ref-type="ref">2009</xref>). Mild cognitive impairment (MCI) is subclinical complaint of memory function in elderly people. It has been reported that 10%&#x02013;20% of individuals over the age of 65&#x000a0;years suffer from MCI (Petersen, <xref rid="brb3936-bib-0044" ref-type="ref">2011</xref>), with high potential of converting to AD (Devanand et&#x000a0;al.,<xref rid="brb3936-bib-0017" ref-type="ref">2008</xref>; Ganguli et&#x000a0;al., <xref rid="brb3936-bib-0026" ref-type="ref">2011</xref>; Petersen et&#x000a0;al., <xref rid="brb3936-bib-0045" ref-type="ref">2001</xref>; Ritchie &#x00026; Touchon, <xref rid="brb3936-bib-0047" ref-type="ref">2000</xref>).</p><p>In addition to its known significance in bone and calcium homeostasis, vitamin D improves protein homeostasis and slows aging (Mark et&#x000a0;al., <xref rid="brb3936-bib-0038" ref-type="ref">2016</xref>). The enzymes involved in conversion of 25(OH)D<sub>3</sub> to 1,25(OH)<sub>2</sub>D<sub>3</sub> are all present in the brain (Harms, Burne, Eyles, &#x00026; McGrath, <xref rid="brb3936-bib-0032" ref-type="ref">2011</xref>). There is a reciprocal relationship between vitamin D and AD. It has been reported that 25(OH)D<sub>3</sub> is reduced in late&#x02010;onset AD, and vitamin D deficiency is regarded as a risk factor for ApoE&#x003b5;4 noncarrier patients with AD (Dursun et&#x000a0;al., <xref rid="brb3936-bib-0019" ref-type="ref">2016</xref>). On the other hand, supplementation with vitamin D derivatives decreases the risk of AD (Dean, Bellgrove, &#x00026; Hall, <xref rid="brb3936-bib-0016" ref-type="ref">2011</xref>). It has recently been found that vitamin D receptors are colocalized with amyloid precursor protein on the neuronal plasma membrane (Dursun &#x00026; Gezen&#x02010;Ak, <xref rid="brb3936-bib-0020" ref-type="ref">2017</xref>). Amyloid &#x003b2; (A&#x003b2;), the pathological hallmark of AD, degrades vitamin D receptor (Dursun, Gezen&#x02010;Ak, &#x00026; Yilmazer, <xref rid="brb3936-bib-0021" ref-type="ref">2010</xref>). Vitamin D decreases the burden of major pathological aggregates in AD, including A&#x003b2; plaques and hyperphosphorylated tau protein (Durk, Han, &#x00026; Chow, <xref rid="brb3936-bib-0018" ref-type="ref">2014</xref>; Yu et&#x000a0;al., <xref rid="brb3936-bib-0054" ref-type="ref">2011</xref>) and augments activity of memantine in AD (Lemire, Brangier, Beaudenon, Duval, &#x00026; Annweiler, <xref rid="brb3936-bib-0036" ref-type="ref">2016</xref>). Moreover, many reports suggest a relationship between vitamin D deficiency with MCI (Annweiler et&#x000a0;al., <xref rid="brb3936-bib-0003" ref-type="ref">2012</xref>; Yin, Fan, Lin, Xu, &#x00026; Zhang, <xref rid="brb3936-bib-0053" ref-type="ref">2015</xref>) and AD (Annweiler et&#x000a0;al., <xref rid="brb3936-bib-0004" ref-type="ref">2010</xref>, <xref rid="brb3936-bib-0002" ref-type="ref">2011</xref>; Landel, Annweiler, Millet, Morello, &#x00026; F&#x000e9;ron, <xref rid="brb3936-bib-0035" ref-type="ref">2016</xref>; Nissou et&#x000a0;al., <xref rid="brb3936-bib-0041" ref-type="ref">2014</xref>; Schl&#x000f6;gl &#x00026; Holick, <xref rid="brb3936-bib-0048" ref-type="ref">2014</xref>).</p><p>There are several measures that could distinguish AD from control subjects. These include decreased metabolism of fluorodeoxyglucose (Silverman et&#x000a0;al., <xref rid="brb3936-bib-0049" ref-type="ref">2001</xref>), increased uptake of amyloid (Small et&#x000a0;al., <xref rid="brb3936-bib-0050" ref-type="ref">2006</xref>), elevated levels of tau or its phosphorylated form, and decreased amyloid &#x003b2;42 in CSF (Hansson et&#x000a0;al., <xref rid="brb3936-bib-0031" ref-type="ref">2006</xref>; Querfurth &#x00026; LaFerla, <xref rid="brb3936-bib-0046" ref-type="ref">2010</xref>; Sunderland et&#x000a0;al., <xref rid="brb3936-bib-0051" ref-type="ref">2003</xref>). However, these approaches are either invasive or very expensive. Therefore, there is still a need for developing diagnosis as well as treatment approaches to diseases characterized by dementia. Also, as to our knowledge, no study of possible use of both 25(OH)D<sub>3</sub> and 1,25(OH)<sub>2</sub>D<sub>3</sub>, separately or in combination with MMSE, as predictors in diagnosis and prediction of MCI and various stages (mild, moderate, and severe) of AD. Accordingly, this study was conducted to evaluate utility of MMSE, serum 25(OH)D<sub>3,</sub> and 1,25(OH)<sub>2</sub>D<sub>3</sub> concentrations in prediction and diagnosis patients with MCI and the various stages of AD.</p></sec><sec id="brb3936-sec-0006"><label>2</label><title>MATERIALS AND METHODS</title><sec id="brb3936-sec-0007"><label>2.1</label><title>Participants</title><p>A total of 230 individuals from Fukuoka University Hospital were included in this study. The participants were allocated to three groups: I&#x02010;Healthy subjects (HS), II&#x02010;patients with MCI and III&#x02010; patients with AD main group classified, according to disease severity, into three stages defined as 1&#x02010;mild AD, 2&#x02010;moderate AD, and 3&#x02010;severe AD. Diagnosis of MCI was performed according to Petersen's criteria (Petersen, <xref rid="brb3936-bib-0044" ref-type="ref">2011</xref>; Petersen et&#x000a0;al., <xref rid="brb3936-bib-0045" ref-type="ref">2001</xref>; Ritchie &#x00026; Touchon, <xref rid="brb3936-bib-0047" ref-type="ref">2000</xref>). The severity of cognitive impairment in patients with AD was evaluated using MMSE scores: mild AD (27&#x000a0;&#x02265;&#x000a0;MMSE&#x000a0;&#x0003e;&#x000a0;20), moderate AD (20&#x000a0;&#x02265;&#x000a0;MMSE&#x000a0;&#x0003e;&#x000a0;10), and severe AD (10&#x000a0;&#x0003e;&#x000a0;MMSE) (Feldman, Van Baelen, Kavanagh, &#x00026; Torfs, <xref rid="brb3936-bib-0024" ref-type="ref">2005</xref>; O'Bryant, Humphreys, &#x00026; Smith, <xref rid="brb3936-bib-0042" ref-type="ref">2008</xref>). Each participant was clinically evaluated by set of tests that included questionnaire and a proxy interview, assessment of past and present illness, neurological and physical examinations, blood chemistry, and neuroimaging with computed tomography and/or magnetic resonance imaging. Some participants in the HS group had hypertension (eight of 33; 24%) and/or hypercholesterolemia (four of 33; 12%), regarded above the baseline blood pressure (systolic 139/diastolic 89&#x000a0;mmHg) and cholesterol (219&#x000a0;mg/dl). All groups were gender&#x02010;balanced except there were two times as many women as men in the moderate and severe AD groups. Moreover, the groups were also age&#x02010;matched except the difference between women moderate AD compared to women HS (<italic>p&#x000a0;</italic>=<italic>&#x000a0;</italic>.23) and men HS (<italic>p&#x000a0;=&#x000a0;</italic>.013). The respective ages (year) of women and men were as follows: HS (74.5&#x000a0;&#x000b1;&#x000a0;6.3; 74.4&#x000a0;&#x000b1;&#x000a0;8.7), MCI (75.5&#x000a0;&#x000b1;&#x000a0;6.8, 77.7&#x000a0;&#x000b1;&#x000a0;11.2), mild AD (74.8&#x000a0;&#x000b1;&#x000a0;8.1; 78.3&#x000a0;&#x000b1;&#x000a0;6.3), moderate AD (82.2&#x000a0;&#x000b1;&#x000a0;5.1; 76.9&#x000a0;&#x000b1;&#x000a0;7.6), and severe AD (77.7&#x000a0;&#x000b1;&#x000a0;8.7; 76.5&#x000a0;&#x000b1;&#x000a0;9.1). A difference was detected only between moderate AD women and HS women (<italic>p&#x000a0;</italic>=<italic>&#x000a0;</italic>0.031), and between moderate AD women and moderate AD men (<italic>p&#x000a0;</italic>=<italic>&#x000a0;</italic>0.016). This difference is consequent to grouping according to the clinical classification to MCI or AD. All participants were free of hepatic and renal disorders. The ethical permission for this study was obtained from the ethical committee of Fukuoka University Hospital. The study was performed in accordance with the ethical standards of the 1964 Helsinki Declaration. Written informed consent was obtained from all participants or their relatives prior to their participation in the study. We excluded participants with any present or earlier history of vitamin D supplementation.</p></sec><sec id="brb3936-sec-0008"><label>2.2</label><title>Samples preparations and analyses</title><p>Peripheral blood was collected from each participant and centrifuged at 400 x <italic>g</italic> for 20&#x000a0;min. The sera obtained were stored at &#x02212;80&#x000b0;C until use. Total serum concentrations of 25(OH)D<sub>3</sub> and 1,25(OH)<sub>2</sub>D<sub>3</sub> were determined by competitive radioimmunoassay using two respective antibodies. A 25&#x02010;OH vitamin D <sup>125</sup>I RIA Kit (DiaSorin Inc. MN, USA) was used to assay 25(OH)D<sub>3</sub>. Briefly, after pretreatment of the samples with acetonitrile 300 to remove proteins, the sample extracts containing 25(OH)D<sub>3</sub> were incubated with <sup>125</sup>I&#x02010;25(OH)D<sub>3</sub> and sheep anti&#x02010;25(OH)D<sub>3</sub> antibody for 90&#x000a0;min at room temperature. Cellulose&#x02010;conjugated anti&#x02010;sheep IgG antibody was added to the precipitated reactive complex and free <sup>125</sup>I&#x02010;25(OH)D<sub>3</sub> was removed by centrifugation. The radioactivity in each precipitate was assayed using a &#x003b3;&#x02010;counter (ARC&#x02010;950, Hitachi&#x02010;Aloka Medical Ltd, Japan), and concentrations were determined according to a standard curve. A 1,25(OH)<sub>2</sub>D<sub>3</sub> RIA Kit (Immunodiagnostic Systems Ltd, Boldon, England) was used to assay 1,25(OH)<sub>2</sub>D<sub>3</sub>. The principle of this assay system was the same as that above except a column technique was also employed to remove lipids during sample pretreatment.</p></sec><sec id="brb3936-sec-0009"><label>2.3</label><title>Statistical analyses</title><p>ANOVA one&#x02010;way was conducted on the variables (age, MMSE, 25(OH)D3 and 1,25(OH)2D3) between groups (HS, MCI, mild AD, moderate AD and severe D), with gender as covariate, to detect the following: 1&#x02010;the main effect, differences between the variables of the groups, 2&#x02010;The groups within each gender, and each gender's variable between groups were compared to evaluate the effects of gender. Homogeneity was verified. Tukey's multiple comparisons post hoc test was applied whenever ANOVA detected significant differences. Bivariate correlations among the variables were evaluated by Pearson's correlation coefficient. As MMSE could be seen as both risk factor and outcome of the disease, a linear regression analysis was also conducted to determine the regression coefficients, statistical significance of regression model (<italic>t</italic> value), and proportion of MMSE (dependent) contributed by independent variables (age, gender, 25(OH)D3, and 1,25(OH)<sub>2</sub>D3) derived from the multiple correlation coefficient (Adjusted <italic>R</italic>
<sup>2</sup>).</p><p>The predictors were also tested with univariate logistic regression analyses to assess the contribution of each predictor alone to each group. Then, multivariate&#x02010;forward selection analyses were conducted to assess the contribution of the predictors in combination to increase the statistical power and account for the individual differences in prediction. Variables which had a <italic>p</italic> value of &#x0003e;.05 were excluded. The followings were calculated: &#x003b2;: logistic regression coefficient describes the size and direction of the relationship between a predictor and the disease (predictive value). Positive predictive value is the probability that a subject classified as a patient by the test belongs in the patient group becomes more likely as the predictor increases. Negative predictive value is the probability that a subject classified as a nonpatient by the test belongs in the nonpatient group. It also indicates the inverse relationship between the predictor and the disease (decreased predictor means increased disease odd). Odd ratio (OR): the ratio of the odds, calculated as the exponent of &#x003b2;. OR is the measurement of likelihood and indicates that when the predictor is raised by one unit the odds ratio of the outcome increase by a factor equal to the OR value, that is, the odds of participants in the dependent variable (patients) increase by a factor equivalent to OR value with 95% confidence interval (CI). Correct classification, CC (accuracy rate (%) of the predictor to diagnose or distinguish two compared variables), and Wald value (significance of predictor contribution) were also measured.</p><p>Receiver operating characteristic (ROC) analysis provides useful information regarding the ability of a predictor to classify subjects into the relevant groups, and to compare the performance of more than one predictor. ROC was conducted to calculate area under the ROC curve (AUC), sensitivity, and specificity. Cutoff values at which optimal balance of sensitivity and specificity can be obtained were derived according to Youden Index. Sensitivity (with optimal 95% confidence interval) is the probability that a test result will be positive when the disease is present (true positive rate&#x02014;the probability that a patient will be accurately classified by the test). Specificity (with optimal 95% confidence interval) is probability that a test result will be negative when the disease is not present (true negative rate&#x02014;the probability that a nonpatient will be accurately classified by the test). The AUC is a measure of the efficacy of the test. The AUC values are typically interpreted as chance (0.0&#x02013;0.4), poor (0.5&#x02013;0.6), weak (0.6&#x02013;0.7), good or acceptable (0.7&#x02013;0.8), excellent or great (0.8&#x02013;0.9), and perfect or outstanding (0.9&#x02013;1.0). The higher the AUC, the more true positive is the result. The positive (LR+) and negative (LR&#x02212;) likelihood ratios are probabilities of respective positive and negative test results. They can be derived from sensitivity and specificity: LR+&#x000a0;=&#x000a0;(Sensitivity or True positive/1&#x000a0;&#x02212;&#x000a0;Specificity or False positive); LR&#x02212;&#x000a0;=&#x000a0;(1&#x000a0;&#x02212;&#x000a0;Sensitivity or False negative/Specificity or True negative).</p><p>The criterion for statistical significance was <italic>p</italic>&#x000a0;&#x0003c;&#x000a0;.05. The values are presented as the mean&#x000a0;&#x000b1;&#x000a0;standard deviation in Figures&#x000a0;<xref rid="brb3936-fig-0001" ref-type="fig">1</xref>, <xref rid="brb3936-fig-0002" ref-type="fig">2</xref>, <xref rid="brb3936-fig-0003" ref-type="fig">3</xref>, and as the standard error in the tables. The data were analyzed, using IBM SPSS Statistics version 23.</p><fig fig-type="Figure" xml:lang="en" id="brb3936-fig-0001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Box plot of <styled-content style="fixed-case">MMSE</styled-content> scores in women (a) and men (b). The lower and upper sides of the boxes indicate the 25th and 75th percentiles. The horizontal lines and black diamonds inside the boxes indicate the median and means, respectively. Shown are also the lower and upper whiskers that indicate the minimum and maximum values, respectively. In women <styled-content style="fixed-case">HS</styled-content>, the upper horizontal bar outside the box with the whisker and the median line inside the box have not appeared because the maximum and 75th percentiles, and median and 25th percentiles are at the same level. In women <styled-content style="fixed-case">MCI</styled-content>, the median line has not appeared because 75th percentiles and median are at the same level. For the same above&#x02010;mentioned reasons, the upper and lower horizontal bars outside the box with the whiskers have not appeared in men <styled-content style="fixed-case">HS</styled-content>. The levels of statistically significant differences are indicated over each point. <styled-content style="fixed-case">AD</styled-content> and <styled-content style="fixed-case">MCI</styled-content> are compared with <styled-content style="fixed-case">HS</styled-content>
</p></caption><graphic id="nlm-graphic-3" xlink:href="BRB3-8-e00936-g001"/></fig><fig fig-type="Figure" xml:lang="en" id="brb3936-fig-0002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Box plot of serum concentrations of 25(<styled-content style="fixed-case">OH</styled-content>)D<sub>3</sub> in women (a) and men (b) <styled-content style="fixed-case">HS</styled-content>,<styled-content style="fixed-case"> MCI</styled-content> and <styled-content style="fixed-case">AD</styled-content>. The lower and upper sides of the boxes indicate the 25th and 75th percentiles. The horizontal lines and black diamonds inside the boxes indicate the median and means, respectively. Shown are also the lower and upper whiskers that indicate the minimum and maximum values, respectively. The levels of statistically significant differences are indicated over each point. Alzheimer's disease (<styled-content style="fixed-case">AD</styled-content>) and mild cognitive impairment (<styled-content style="fixed-case">MCI</styled-content>) compared with healthy subjects (<styled-content style="fixed-case">HS</styled-content>)</p></caption><graphic id="nlm-graphic-5" xlink:href="BRB3-8-e00936-g002"/></fig><fig fig-type="Figure" xml:lang="en" id="brb3936-fig-0003" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Box plot of serum concentrations of 1,25(<styled-content style="fixed-case">OH</styled-content>)D<sub>3</sub> in women (a) and men (b). The lower and upper sides of the boxes indicate the 25th and 75th percentiles. The horizontal lines and black diamonds inside the boxes indicate the median and means, respectively. Shown are also the lower and upper whiskers that indicate the minimum and maximum values, respectively. No significant differences were detected among healthy subjects (<styled-content style="fixed-case">HS</styled-content>), patients with mild cognitive impairment (<styled-content style="fixed-case">MCI</styled-content>), and patients with Alzheimer's disease (<styled-content style="fixed-case">AD</styled-content>)</p></caption><graphic id="nlm-graphic-7" xlink:href="BRB3-8-e00936-g003"/></fig></sec></sec><sec id="brb3936-sec-0010"><label>3</label><title>RESULTS</title><sec id="brb3936-sec-0011"><label>3.1</label><title>MMSE scores in patients with MCI and AD</title><p>The MMSE scores of HS women and men were 28.0&#x000a0;&#x000b1;&#x000a0;1.9, 29.1&#x000a0;&#x000b1;&#x000a0;0.9, respectively. Figure&#x000a0;<xref rid="brb3936-fig-0001" ref-type="fig">1</xref> shows that MMSE scores were decreased in MCI and AD. A significant difference for the main effect, between groups, was detected for MMSE (<italic>F</italic>(4,225)&#x000a0;=&#x000a0;722.076; <italic>p&#x000a0;</italic>=<italic>&#x000a0;</italic>.000). There was no difference in the MMSE values between women (26.0&#x000a0;&#x000b1;&#x000a0;2.4) and men (26.0&#x000a0;&#x000b1;&#x000a0;1.8) with MCI. The MMSE scores were decreased in mild AD (women 23.9&#x000a0;&#x000b1;&#x000a0;2.0, men 23.2&#x000a0;&#x000b1;&#x000a0;1.6), moderate AD (women 16.1&#x000a0;&#x000b1;&#x000a0;2.5, men 17.5&#x000a0;&#x000b1;&#x000a0;2.0), and severe AD (women 4.6&#x000a0;&#x000b1;&#x000a0;4.1, men 4.5&#x000a0;&#x000b1;&#x000a0;3.4). The decrease in MMSE scores in AD was more than that observed in MCI in both genders (<italic>p&#x000a0;</italic>=<italic>&#x000a0;</italic>.000 for moderate and severe AD vs. MCI) except in mild AD (women, <italic>p&#x000a0;</italic>=<italic>&#x000a0;</italic>.030; men, <italic>p&#x000a0;</italic>=<italic>&#x000a0;</italic>.002 vs. MCI). In addition, significant differences (<italic>p&#x000a0;</italic>=<italic>&#x000a0;</italic>.000) were detected among the various stages of AD in women and men analyzed separately. However, no significant gender&#x02010;dependent difference was detected for the same stage of AD between women and men when compared to each other.</p></sec><sec id="brb3936-sec-0012"><label>3.2</label><title>Serum 25(OH)D<sub>3</sub> concentrations in patients with MCI and AD</title><p>In HS, the mean serum concentrations of 25(OH)D<sub>3</sub> were 26.18&#x000a0;&#x000b1;&#x000a0;7.18&#x000a0;ng/ml and 27.42&#x000a0;&#x000b1;&#x000a0;8.05&#x000a0;ng/ml in women and men participants, respectively. A significant (<italic>F</italic>(4,225)&#x000a0;=&#x000a0;25.869, <italic>p&#x000a0;</italic>=<italic>&#x000a0;</italic>.000) main effect of 25(OH)D<sub>3</sub> was obtained in MCI and AD. Figure&#x000a0;<xref rid="brb3936-fig-0002" ref-type="fig">2</xref> shows that concentrations of 25(OH)D<sub>3</sub> in patients with MCI were lower than HS in both women (18.23&#x000a0;&#x000b1;&#x000a0;5.11&#x000a0;ng/ml; <italic>p&#x000a0;</italic>=<italic>&#x000a0;</italic>.000) and men (21.03&#x000a0;&#x000b1;&#x000a0;6.99&#x000a0;ng/ml; <italic>p&#x000a0;</italic>=<italic>&#x000a0;</italic>.003). However, the concentrations of 25(OH)D<sub>3</sub> in MCI were not different from AD in both genders.</p><p>Figure&#x000a0;<xref rid="brb3936-fig-0002" ref-type="fig">2</xref>a shows that in AD women patients, 25(OH)D<sub>3</sub> concentrations in mild AD (17.75&#x000a0;&#x000b1;&#x000a0;5.30&#x000a0;ng/ml), moderate AD (16.79&#x000a0;&#x000b1;&#x000a0;5.32&#x000a0;ng/ml), and severe AD (13.95&#x000a0;&#x000b1;&#x000a0;5.08&#x000a0;ng/ml) were significantly lower than HS (<italic>p&#x000a0;</italic>=<italic>&#x000a0;</italic>.000). On the other hand, it can be seen from Figure&#x000a0;<xref rid="brb3936-fig-0002" ref-type="fig">2</xref>b that in the men patients, the concentrations of 25(OH)D<sub>3</sub> were significantly (<italic>p&#x000a0;</italic>=<italic>&#x000a0;</italic>.000) lower than HS in mild AD (17.59&#x000a0;&#x000b1;&#x000a0;6.95&#x000a0;ng/ml) and severe AD (15.36&#x000a0;&#x000b1;&#x000a0;4.08&#x000a0;ng/ml). However, no significant (<italic>p&#x000a0;</italic>=<italic>&#x000a0;</italic>.105) difference was detected between HS and the moderate AD (21.09&#x000a0;&#x000b1;&#x000a0;6.32&#x000a0;ng/ml). No significant difference was detected among the AD stages for the same gender, or between the genders in each group.</p></sec><sec id="brb3936-sec-0013"><label>3.3</label><title>Serum 1,25(OH)<sub>2</sub>D<sub>3</sub> concentrations in patients with MCI and AD</title><p>In HS, the mean serum concentrations of 1,25(OH<italic><bold>)</bold></italic>
<sub>2</sub>D<sub>3</sub> were 53.05&#x000a0;&#x000b1;&#x000a0;13.04&#x000a0;pg/ml and 54.12&#x000a0;&#x000b1;&#x000a0;14.34&#x000a0;pg/ml in women and men participants, respectively. Figure&#x000a0;<xref rid="brb3936-fig-0003" ref-type="fig">3</xref>a shows that, in women, the concentrations of 1,25(OH)<sub>2</sub>D<sub>3</sub> were 55.38&#x000a0;&#x000b1;&#x000a0;22.85&#x000a0;pg/ml (MCI), 62.53&#x000a0;&#x000b1;&#x000a0;17.03&#x000a0;pg/ml (mild AD), 54.22&#x000a0;&#x000b1;&#x000a0;13.71&#x000a0;pg/ml (moderate AD), and 61.84&#x000a0;&#x000b1;&#x000a0;26.45&#x000a0;pg/ml (severe AD). Moreover, Figure&#x000a0;<xref rid="brb3936-fig-0003" ref-type="fig">3</xref>b shows that, in men, the concentrations of 1,25(OH)<sub>2</sub>D<sub>3</sub> were 55.01&#x000a0;&#x000b1;&#x000a0;18.00&#x000a0;pg/ml (MCI), 53.52&#x000a0;&#x000b1;&#x000a0;19.20&#x000a0;pg/ml (mild AD), 57.02&#x000a0;&#x000b1;&#x000a0;15.03&#x000a0;pg/ml (moderate AD), and 48.25&#x000a0;&#x000b1;&#x000a0;9.55&#x000a0;pg/ml (severe AD). No significant difference among the groups was detected (<italic>F</italic>(4,225)&#x000a0;=&#x000a0;0.583, <italic>p&#x000a0;</italic>=<italic>&#x000a0;</italic>.676).</p></sec><sec id="brb3936-sec-0014"><label>3.4</label><title>Correlations among MMSE, 25(OH)D<sub>3,</sub> and 1,25(OH)<sub>2</sub>D<sub>3</sub>
</title><p>Table&#x000a0;<xref rid="brb3936-tbl-0001" ref-type="table-wrap">1</xref> and Figure&#x000a0;<xref rid="brb3936-fig-0004" ref-type="fig">4</xref> show that no correlation was evident in HS. On the other hand, in MCI, the largest and significant correlation was detected in men between 25(OH)D<sub>3</sub> and 1,25(OH)<sub>2</sub>D<sub>3</sub> (<italic>r</italic>&#x000a0;=&#x000a0;.456, <italic>p&#x000a0;</italic>=<italic>&#x000a0;</italic>.011) in addition to the correlation between 25(OH)D<sub>3</sub> and MMSE (<italic>r</italic>&#x000a0;=&#x000a0;.330, <italic>p&#x000a0;</italic>=<italic>&#x000a0;</italic>.022), and 1,25(OH) <sub>2</sub>D<sub>3</sub> (<italic>r</italic>&#x000a0;=&#x000a0;&#x02212;.356, <italic>p&#x000a0;</italic>=<italic>&#x000a0;</italic>.048). The total correlation between 25(OH)D<sub>3</sub> and 1,25(OH)<sub>2</sub>D3 in both genders was significant (<italic>r</italic>&#x000a0;=&#x000a0;.254, <italic>p&#x000a0;</italic>=<italic>&#x000a0;</italic>.05). No significant correlation was observed in women with MCI.</p><table-wrap id="brb3936-tbl-0001" xml:lang="en" orientation="portrait" position="float"><label>Table 1</label><caption><p>Correlations among MMSE, 25 (OH)D3 and. 1,25(OH)2 D3 in healthy subjects (HS) and patients with mild cognitive impairment (MCI) and Alzheimer's diseases (AD)</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><thead valign="top"><tr style="border-bottom:solid 1px #000000"><th align="left" colspan="3" valign="top" rowspan="1">Women</th><th align="left" valign="top" rowspan="1" colspan="1">25 (OH)D3</th><th align="left" valign="top" rowspan="1" colspan="1">1,25 (OH)2 D3</th><th align="left" colspan="3" valign="top" rowspan="1">Men</th><th align="left" valign="top" rowspan="1" colspan="1">25 (OH)D3</th><th align="left" valign="top" rowspan="1" colspan="1">1,25 (OH)2 D3</th></tr></thead><tbody><tr><td align="left" rowspan="4" colspan="1">HS (<italic>n</italic>&#x000a0;=&#x000a0;28)</td><td align="left" rowspan="2" colspan="1">MMSE</td><td align="left" rowspan="1" colspan="1">
<italic>r</italic>
</td><td align="left" rowspan="1" colspan="1">.122</td><td align="left" rowspan="1" colspan="1">.147</td><td align="left" rowspan="4" colspan="1">HS (<italic>n</italic>&#x000a0;=&#x000a0;33)</td><td align="left" rowspan="2" colspan="1">MMSE</td><td align="left" rowspan="1" colspan="1">
<italic>r</italic>
</td><td align="left" rowspan="1" colspan="1">&#x02212;.139</td><td align="left" rowspan="1" colspan="1">&#x02212;.134</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>p</italic>
</td><td align="left" rowspan="1" colspan="1">.535</td><td align="left" rowspan="1" colspan="1">.258</td><td align="left" rowspan="1" colspan="1">
<italic>p</italic>
</td><td align="left" rowspan="1" colspan="1">.441</td><td align="left" rowspan="1" colspan="1">.457</td></tr><tr><td align="left" rowspan="2" colspan="1">25(OH)D3</td><td align="left" rowspan="1" colspan="1">
<italic>r</italic>
</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">&#x02212;.041</td><td align="left" rowspan="2" colspan="1">25(OH)D3</td><td align="left" rowspan="1" colspan="1">
<italic>r</italic>
</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">&#x02212;.248</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>p</italic>
</td><td align="left" rowspan="1" colspan="1">&#x02014;</td><td align="left" rowspan="1" colspan="1">.836</td><td align="left" rowspan="1" colspan="1">
<italic>p</italic>
</td><td align="left" rowspan="1" colspan="1">&#x02014;</td><td align="left" rowspan="1" colspan="1">.165</td></tr><tr><td align="left" rowspan="4" colspan="1">MCI (<italic>n</italic>&#x000a0;=&#x000a0;31)</td><td align="left" rowspan="2" colspan="1">MMSE</td><td align="left" rowspan="1" colspan="1">
<italic>r</italic>
</td><td align="left" rowspan="1" colspan="1">&#x02212;.016</td><td align="left" rowspan="1" colspan="1">&#x02212;.288</td><td align="left" rowspan="4" colspan="1">MCI (<italic>n</italic>&#x000a0;=&#x000a0;30)</td><td align="left" rowspan="2" colspan="1">MMSE</td><td align="left" rowspan="1" colspan="1">
<italic>r</italic>
</td><td align="left" rowspan="1" colspan="1">.330</td><td align="left" rowspan="1" colspan="1">&#x02212;.365</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>p</italic>
</td><td align="left" rowspan="1" colspan="1">.932</td><td align="left" rowspan="1" colspan="1">.115</td><td align="left" rowspan="1" colspan="1">
<italic>p</italic>
</td><td align="left" rowspan="1" colspan="1">.022<xref ref-type="fn" rid="brb3936-note-0002">a</xref>
</td><td align="left" rowspan="1" colspan="1">.048<xref ref-type="fn" rid="brb3936-note-0002">a</xref>
</td></tr><tr><td align="left" rowspan="2" colspan="1">25(OH)D3</td><td align="left" rowspan="1" colspan="1">
<italic>r</italic>
</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">.082</td><td align="left" rowspan="2" colspan="1">25(OH)D3</td><td align="left" rowspan="1" colspan="1">
<italic>r</italic>
</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">.456</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>p</italic>
</td><td align="left" rowspan="1" colspan="1">&#x02014;</td><td align="left" rowspan="1" colspan="1">.66</td><td align="left" rowspan="1" colspan="1">
<italic>p</italic>
</td><td align="left" rowspan="1" colspan="1">&#x02014;</td><td align="left" rowspan="1" colspan="1">.011<xref ref-type="fn" rid="brb3936-note-0002">a</xref>
</td></tr><tr><td align="left" rowspan="4" colspan="1">Mild AD (<italic>n</italic>&#x000a0;=&#x000a0;24)</td><td align="left" rowspan="2" colspan="1">MMSE</td><td align="left" rowspan="1" colspan="1">
<italic>r</italic>
</td><td align="left" rowspan="1" colspan="1">&#x02212;.086</td><td align="left" rowspan="1" colspan="1">&#x02212;.099</td><td align="left" rowspan="4" colspan="1">Mild AD (<italic>n</italic>&#x000a0;=&#x000a0;17)</td><td align="left" rowspan="2" colspan="1">MMSE</td><td align="left" rowspan="1" colspan="1">
<italic>r</italic>
</td><td align="left" rowspan="1" colspan="1">.052</td><td align="left" rowspan="1" colspan="1">&#x02212;.275</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>p</italic>
</td><td align="left" rowspan="1" colspan="1">.689</td><td align="left" rowspan="1" colspan="1">.645</td><td align="left" rowspan="1" colspan="1">
<italic>p</italic>
</td><td align="left" rowspan="1" colspan="1">.842</td><td align="left" rowspan="1" colspan="1">.285</td></tr><tr><td align="left" rowspan="2" colspan="1">25(OH)D3</td><td align="left" rowspan="1" colspan="1">
<italic>r</italic>
</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">.487</td><td align="left" rowspan="2" colspan="1">25(OH)D3</td><td align="left" rowspan="1" colspan="1">
<italic>r</italic>
</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">.163</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>p</italic>
</td><td align="left" rowspan="1" colspan="1">&#x02014;</td><td align="left" rowspan="1" colspan="1">.016<xref ref-type="fn" rid="brb3936-note-0002">a</xref>
</td><td align="left" rowspan="1" colspan="1">
<italic>p</italic>
</td><td align="left" rowspan="1" colspan="1">&#x02014;</td><td align="left" rowspan="1" colspan="1">.531</td></tr><tr><td align="left" rowspan="4" colspan="1">Moderate AD (<italic>n</italic>&#x000a0;=&#x000a0;24)</td><td align="left" rowspan="2" colspan="1">MMSE</td><td align="left" rowspan="1" colspan="1">
<italic>r</italic>
</td><td align="left" rowspan="1" colspan="1">&#x02212;.326</td><td align="left" rowspan="1" colspan="1">.148</td><td align="left" rowspan="4" colspan="1">Moderate AD (<italic>n</italic>&#x000a0;=&#x000a0;11)</td><td align="left" rowspan="2" colspan="1">MMSE</td><td align="left" rowspan="1" colspan="1">
<italic>r</italic>
</td><td align="left" rowspan="1" colspan="1">&#x02212;.415</td><td align="left" rowspan="1" colspan="1">&#x02212;.280</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>p</italic>
</td><td align="left" rowspan="1" colspan="1">.048<xref ref-type="fn" rid="brb3936-note-0002">a</xref>
</td><td align="left" rowspan="1" colspan="1">.49</td><td align="left" rowspan="1" colspan="1">
<italic>p</italic>
</td><td align="left" rowspan="1" colspan="1">.205</td><td align="left" rowspan="1" colspan="1">.404</td></tr><tr><td align="left" rowspan="2" colspan="1">25(OH)D3</td><td align="left" rowspan="1" colspan="1">
<italic>r</italic>
</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">.357</td><td align="left" rowspan="2" colspan="1">25(OH)D3</td><td align="left" rowspan="1" colspan="1">
<italic>r</italic>
</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">.156</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>p</italic>
</td><td align="left" rowspan="1" colspan="1">&#x02014;</td><td align="left" rowspan="1" colspan="1">.087</td><td align="left" rowspan="1" colspan="1">
<italic>p</italic>
</td><td align="left" rowspan="1" colspan="1">&#x02014;</td><td align="left" rowspan="1" colspan="1">.647</td></tr><tr><td align="left" rowspan="4" colspan="1">Severe AD (<italic>n</italic>&#x000a0;=&#x000a0;21)</td><td align="left" rowspan="2" colspan="1">MMSE</td><td align="left" rowspan="1" colspan="1">
<italic>r</italic>
</td><td align="left" rowspan="1" colspan="1">&#x02212;.331</td><td align="left" rowspan="1" colspan="1">.239</td><td align="left" rowspan="4" colspan="1">Severe AD (<italic>n</italic>&#x000a0;=&#x000a0;11)</td><td align="left" rowspan="2" colspan="1">MMSE</td><td align="left" rowspan="1" colspan="1">
<italic>r</italic>
</td><td align="left" rowspan="1" colspan="1">.138</td><td align="left" rowspan="1" colspan="1">.056</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>p</italic>
</td><td align="left" rowspan="1" colspan="1">.023<xref ref-type="fn" rid="brb3936-note-0002">a</xref>
</td><td align="left" rowspan="1" colspan="1">.297</td><td align="left" rowspan="1" colspan="1">
<italic>p</italic>
</td><td align="left" rowspan="1" colspan="1">.687</td><td align="left" rowspan="1" colspan="1">.87</td></tr><tr><td align="left" rowspan="2" colspan="1">25(OH)D3</td><td align="left" rowspan="1" colspan="1">
<italic>r</italic>
</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">.62</td><td align="left" rowspan="2" colspan="1">25(OH)D3</td><td align="left" rowspan="1" colspan="1">
<italic>r</italic>
</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">.024</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>p</italic>
</td><td align="left" rowspan="1" colspan="1">&#x02014;</td><td align="left" rowspan="1" colspan="1">.003<xref ref-type="fn" rid="brb3936-note-0002">a</xref>
</td><td align="left" rowspan="1" colspan="1">
<italic>p</italic>
</td><td align="left" rowspan="1" colspan="1">&#x02014;</td><td align="left" rowspan="1" colspan="1">.944</td></tr></tbody></table><table-wrap-foot><fn id="brb3936-note-0001"><p>The correlation coefficient magnitude (<italic>r</italic>) is determined according to Pearson's correlation: small (<italic>r</italic>&#x000a0;=&#x000a0;.1), medium (<italic>r</italic>&#x000a0;=&#x000a0;.3), and large (<italic>r&#x000a0;</italic>=&#x000a0;&#x0003e;.5).</p></fn><fn id="brb3936-note-0002"><label>a</label><p>Significant correlation.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd</copyright-holder></permissions></table-wrap><fig fig-type="Figure" xml:lang="en" id="brb3936-fig-0004" orientation="portrait" position="float"><label>Figure 4</label><caption><p>Correlations between serum 25(<styled-content style="fixed-case">OH</styled-content>)D<sub>3</sub> and 1,25(<styled-content style="fixed-case">OH</styled-content>)<sub>2</sub>D<sub>3</sub> concentrations in women and men healthy subjects (<styled-content style="fixed-case">HS</styled-content>), mild cognitive impairment (<styled-content style="fixed-case">MCI</styled-content>), and Alzheimer's disease (<styled-content style="fixed-case">AD</styled-content>). Shown are also the total correlation values for both genders in combination (total) in each group</p></caption><graphic id="nlm-graphic-9" xlink:href="BRB3-8-e00936-g004"/></fig><p>In patients with AD, significant correlations were detected only in women. MMSE was correlated only with 25(OH)D<sub>3</sub> in moderate AD (<italic>r</italic>&#x000a0;=&#x000a0;&#x02212;.326, <italic>p&#x000a0;</italic>=<italic>&#x000a0;</italic>.048) and severe AD (<italic>r</italic>&#x000a0;=&#x000a0;&#x02212;.331, <italic>p&#x000a0;</italic>=<italic>&#x000a0;</italic>.023), indicating to a parallel decrease of MMSE with 25(OH)D<sub>3</sub>, but not 1,25(OH)<sub>2</sub>D<sub>3</sub>. On the other hand, the largest correlation was detected between 25(OH)D<sub>3</sub> and 1,25(OH)<sub>2</sub>D<sub>3</sub> in severe AD (<italic>r</italic>&#x000a0;=&#x000a0;.62; <italic>p&#x000a0;</italic>=<italic>&#x000a0;</italic>.003) followed by mild AD (<italic>r</italic>&#x000a0;=&#x000a0;.487, <italic>p&#x000a0;</italic>=<italic>&#x000a0;</italic>.016). There was no significant correlation between 25(OH)D<sub>3</sub> and 1,25(OH)<sub>2</sub>D<sub>3</sub> in moderate AD (<italic>r</italic>&#x000a0;=&#x000a0;.357, <italic>p&#x000a0;</italic>=<italic>&#x000a0;</italic>.087). The correlation of 25(OH)D<sub>3</sub> and 1,25(OH)<sub>2</sub>D<sub>3</sub> values of all stages together was significant in women (<italic>r</italic>&#x000a0;=&#x000a0;.488, <italic>p&#x000a0;</italic>=<italic>&#x000a0;</italic>.016) but not in men (<italic>r</italic>&#x000a0;=&#x000a0;.114, <italic>p&#x000a0;</italic>=<italic>&#x000a0;</italic>.710). The total correlation between 25(OH)D<sub>3</sub> and 1,25(OH)<sub>2</sub>D<sub>3</sub> for both genders was not significant (<italic>r</italic>&#x000a0;=&#x000a0;.301, <italic>p&#x000a0;</italic>=<italic>&#x000a0;</italic>.372).</p><p>The linear regression established that only gender could significantly predict MMSE (<italic>B</italic>&#x000a0;=&#x000a0;0.325, <italic>t</italic>&#x000a0;=&#x000a0;2.638, <italic>p&#x000a0;</italic>=<italic>&#x000a0;</italic>.011) and account for 11% (adjusted <italic>R</italic>
<sup>2</sup>) of MMSE variability in HS. On the other hand, although both 25(OH)D<sub>3</sub> and 1,25(OH)<sub>2</sub>D<sub>3</sub> contributed to MMSE variability in MCI, 1,25(OH) <sub>2</sub>D<sub>3</sub> accounted for only 3% of the variability (<italic>p&#x000a0;</italic>=<italic>&#x000a0;</italic>.075), while 25(OH)D<sub>3</sub> significantly (<italic>p&#x000a0;</italic>=<italic>&#x000a0;</italic>.0001) contributed (16%) to MMSE variability. On the other hand, in AD, only 25(OH)D<sub>3</sub> could significantly (<italic>p&#x000a0;</italic>=<italic>&#x000a0;</italic>.000) affect MMSE and accounts for 26% of MMSE variability (Table&#x000a0;<xref rid="brb3936-tbl-0002" ref-type="table-wrap">2</xref>).</p><table-wrap id="brb3936-tbl-0002" xml:lang="en" orientation="portrait" position="float"><label>Table 2</label><caption><p>Linear regression of gender, 25(OH)D3 and 1,25(OH)2D3 with MMSE in healthy subjects (HS) and patients with mild cognitive impairment (MCI) and Alzheimer's diseases (AD)</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><thead valign="top"><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="2" valign="top" colspan="1">Group</th><th align="left" rowspan="2" valign="top" colspan="1">Model</th><th align="left" rowspan="2" valign="top" colspan="1">Predictor</th><th align="left" rowspan="2" valign="top" colspan="1">USC B</th><th align="left" rowspan="2" valign="top" colspan="1">
<italic>SE</italic>
</th><th align="left" rowspan="2" valign="top" colspan="1">SC Beta</th><th align="left" rowspan="2" valign="top" colspan="1">
<italic>t</italic> value</th><th align="left" rowspan="2" valign="top" colspan="1">Sig.</th><th align="left" colspan="2" style="border-bottom:solid 1px #000000" valign="top" rowspan="1">95% CI for B</th><th align="left" rowspan="2" valign="top" colspan="1">
<italic>R</italic>
<sup>2</sup>
</th><th align="left" rowspan="2" valign="top" colspan="1">Adjusted <italic>R</italic>
<sup>2</sup>
</th></tr><tr style="border-bottom:solid 1px #000000"><th align="left" valign="top" rowspan="1" colspan="1">Lower bound</th><th align="left" valign="top" rowspan="1" colspan="1">Upper bound</th></tr></thead><tbody><tr><td align="left" rowspan="3" colspan="1">HS</td><td align="left" rowspan="1" colspan="1">Univariate</td><td align="left" rowspan="1" colspan="1">25(OH)D3</td><td align="left" rowspan="1" colspan="1">0.004</td><td align="left" rowspan="1" colspan="1">0.019</td><td align="left" rowspan="1" colspan="1">0.024</td><td align="left" rowspan="1" colspan="1">0.186</td><td align="left" rowspan="1" colspan="1">0.853</td><td align="left" rowspan="1" colspan="1">0.035</td><td align="left" rowspan="1" colspan="1">0.042</td><td align="left" rowspan="1" colspan="1">.001</td><td align="left" rowspan="1" colspan="1">&#x02212;.016</td></tr><tr><td align="left" rowspan="1" colspan="1">Univariate</td><td align="left" rowspan="1" colspan="1">1,25(OH)2D3</td><td align="left" rowspan="1" colspan="1">0.012</td><td align="left" rowspan="1" colspan="1">0.011</td><td align="left" rowspan="1" colspan="1">0.147</td><td align="left" rowspan="1" colspan="1">1.142</td><td align="left" rowspan="1" colspan="1">0.258</td><td align="left" rowspan="1" colspan="1">0.009</td><td align="left" rowspan="1" colspan="1">0.033</td><td align="left" rowspan="1" colspan="1">.022</td><td align="left" rowspan="1" colspan="1">.005</td></tr><tr><td align="left" rowspan="1" colspan="1">Multivariate</td><td align="left" rowspan="1" colspan="1">Gender</td><td align="left" rowspan="1" colspan="1">0.723</td><td align="left" rowspan="1" colspan="1">0.274</td><td align="left" rowspan="1" colspan="1">0.325</td><td align="left" rowspan="1" colspan="1">2.638</td><td align="left" rowspan="1" colspan="1">0.011<xref ref-type="fn" rid="brb3936-note-0003">*</xref>
</td><td align="left" rowspan="1" colspan="1">0.175</td><td align="left" rowspan="1" colspan="1">1.271</td><td align="left" rowspan="1" colspan="1">.106</td><td align="left" rowspan="1" colspan="1">.09</td></tr><tr><td align="left" rowspan="3" colspan="1">MCI</td><td align="left" rowspan="1" colspan="1">Univariate</td><td align="left" rowspan="1" colspan="1">25(OH)D3</td><td align="left" rowspan="1" colspan="1">0.098</td><td align="left" rowspan="1" colspan="1">0.024</td><td align="left" rowspan="1" colspan="1">0.346</td><td align="left" rowspan="1" colspan="1">4.041</td><td align="left" rowspan="1" colspan="1">0.0001<xref ref-type="fn" rid="brb3936-note-0003">*</xref>
</td><td align="left" rowspan="1" colspan="1">0.05</td><td align="left" rowspan="1" colspan="1">0.145</td><td align="left" rowspan="1" colspan="1">.12</td><td align="left" rowspan="1" colspan="1">.112</td></tr><tr><td align="left" rowspan="1" colspan="1">Univariate</td><td align="left" rowspan="1" colspan="1">1,25(OH)2D3</td><td align="left" rowspan="1" colspan="1">&#x02010;0.023</td><td align="left" rowspan="1" colspan="1">0.011</td><td align="left" rowspan="1" colspan="1">0.177</td><td align="left" rowspan="1" colspan="1">1.973</td><td align="left" rowspan="1" colspan="1">0.075</td><td align="left" rowspan="1" colspan="1">0.045</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">.031</td><td align="left" rowspan="1" colspan="1">.023</td></tr><tr><td align="left" rowspan="1" colspan="1">Multivariate</td><td align="left" rowspan="1" colspan="1">25(OH)D3</td><td align="left" rowspan="1" colspan="1">0.098</td><td align="left" rowspan="1" colspan="1">0.024</td><td align="left" rowspan="1" colspan="1">0.346</td><td align="left" rowspan="1" colspan="1">4,041</td><td align="left" rowspan="1" colspan="1">0.0001<xref ref-type="fn" rid="brb3936-note-0003">*</xref>
</td><td align="left" rowspan="1" colspan="1">0.05</td><td align="left" rowspan="1" colspan="1">0.145</td><td align="left" rowspan="1" colspan="1">.12</td><td align="left" rowspan="1" colspan="1">.112</td></tr><tr><td align="left" rowspan="3" colspan="1">AD</td><td align="left" rowspan="1" colspan="1">Univariate</td><td align="left" rowspan="1" colspan="1">25(OH)D3</td><td align="left" rowspan="1" colspan="1">0.572</td><td align="left" rowspan="1" colspan="1">0.076</td><td align="left" rowspan="1" colspan="1">0.506</td><td align="left" rowspan="1" colspan="1">7.574</td><td align="left" rowspan="1" colspan="1">0.0001<xref ref-type="fn" rid="brb3936-note-0003">*</xref>
</td><td align="left" rowspan="1" colspan="1">0.423</td><td align="left" rowspan="1" colspan="1">0.722</td><td align="left" rowspan="1" colspan="1">.256</td><td align="left" rowspan="1" colspan="1">.251</td></tr><tr><td align="left" rowspan="1" colspan="1">Univariate</td><td align="left" rowspan="1" colspan="1">1,25(OH)2D3</td><td align="left" rowspan="1" colspan="1">&#x02212;0.014</td><td align="left" rowspan="1" colspan="1">0.042</td><td align="left" rowspan="1" colspan="1">0.026</td><td align="left" rowspan="1" colspan="1">0.34</td><td align="left" rowspan="1" colspan="1">0.735</td><td align="left" rowspan="1" colspan="1">&#x02212;0.097</td><td align="left" rowspan="1" colspan="1">0.068</td><td align="left" rowspan="1" colspan="1">.001</td><td align="left" rowspan="1" colspan="1">.005</td></tr><tr><td align="left" rowspan="1" colspan="1">Multivariate</td><td align="left" rowspan="1" colspan="1">25(OH)D3</td><td align="left" rowspan="1" colspan="1">0.572</td><td align="left" rowspan="1" colspan="1">0.076</td><td align="left" rowspan="1" colspan="1">0.506</td><td align="left" rowspan="1" colspan="1">7.574</td><td align="left" rowspan="1" colspan="1">0.0001<xref ref-type="fn" rid="brb3936-note-0003">*</xref>
</td><td align="left" rowspan="1" colspan="1">0.423</td><td align="left" rowspan="1" colspan="1">0.722</td><td align="left" rowspan="1" colspan="1">.256</td><td align="left" rowspan="1" colspan="1">.251</td></tr></tbody></table><table-wrap-foot><fn id="brb3936-note-0003"><p>USC B: unstandardized regression coefficient; SC Beta: standardized coefficient; <italic>R</italic>
<sup>2</sup>: squared multiple correlation coefficient; <italic>SE</italic>: standard errors of the regression coefficients; Sig: two&#x02010;sided observed significance levels (<italic>p</italic>) for the <italic>t</italic> statistics. CI: confidence interval; *Significant <italic>p</italic> values. The predictors 25(OH)D3, 1,25(OH)2D3 and gender (independent variable) were used to predict MMSE (dependent variable).</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd</copyright-holder></permissions></table-wrap></sec><sec id="brb3936-sec-0015"><label>3.5</label><title>Receiver operating characteristic (ROC) analysis</title><p>Table&#x000a0;<xref rid="brb3936-tbl-0003" ref-type="table-wrap">3</xref> shows that MMSE displayed an excellent&#x02013;perfect diagnostic power and differentiating MCI from HS, various AD stages among themselves and each stage from HS. However, MMSE exhibited the same or close sensitivity and specificity values. The highest cutoff value was obtained in MCI and AD when evaluated against HS. Moreover, higher LR+ and lower LR&#x02212; for MMSE were observed in MCI and mild AD combined with HS (data not shown). On the other hand, an excellent&#x02013;perfect differential diagnostic power was detected for 25(OH)D<sub>3</sub> when either MCI or AD subgroups were evaluated against HS. However, 25(OH)D<sub>3</sub> exhibited poor&#x02013;weak power when the differential diagnosis was analyzed among the stages of AD. Moreover, high sensitivity and low specificity were obtained for 25(OH)D<sub>3</sub> especially in MCI and AD when evaluated against HS. The cutoff value of 25(OH)D<sub>3</sub> was higher than MMSE, especially in patients with AD whether evaluated against HS or other groups of AD. Moreover, higher (10 times) LR+ than LR&#x02212; was observed for 25(OH)D3 (data not shown).</p><table-wrap id="brb3936-tbl-0003" xml:lang="en" orientation="portrait" position="float"><label>Table 3</label><caption><p>Bivariate receiver operating characteristic (ROC) analysis of the study groups</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><thead valign="top"><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="2" valign="top" colspan="1"/><th align="left" rowspan="2" valign="top" colspan="1"/><th align="left" rowspan="2" valign="top" colspan="1">AUC</th><th align="left" rowspan="2" valign="top" colspan="1">
<italic>SE</italic>
</th><th align="left" rowspan="2" valign="top" colspan="1">Sig</th><th align="left" colspan="2" style="border-bottom:solid 1px #000000" valign="top" rowspan="1">CI (95%)</th><th align="left" rowspan="2" valign="top" colspan="1">Cut&#x02010; off<xref ref-type="fn" rid="brb3936-note-0005">a</xref>
</th><th align="left" rowspan="2" valign="top" colspan="1">Sensitivity</th><th align="left" rowspan="2" valign="top" colspan="1">Specificity</th></tr><tr style="border-bottom:solid 1px #000000"><th align="left" valign="top" rowspan="1" colspan="1">Lower Bound</th><th align="left" valign="top" rowspan="1" colspan="1">Upper Bound</th></tr></thead><tbody><tr><td align="left" rowspan="3" colspan="1">MCI vs. HS</td><td align="left" rowspan="1" colspan="1">MMSE</td><td align="left" rowspan="1" colspan="1">0.906</td><td align="left" rowspan="1" colspan="1">0.03</td><td align="left" rowspan="1" colspan="1">0.0001<xref ref-type="fn" rid="brb3936-note-0006">b</xref>
</td><td align="left" rowspan="1" colspan="1">0.847</td><td align="left" rowspan="1" colspan="1">0.965</td><td align="left" rowspan="1" colspan="1">27.5</td><td align="left" rowspan="1" colspan="1">0.82</td><td align="left" rowspan="1" colspan="1">0.984</td></tr><tr><td align="left" rowspan="1" colspan="1">25 (OH)D3</td><td align="left" rowspan="1" colspan="1">0.765</td><td align="left" rowspan="1" colspan="1">0.04</td><td align="left" rowspan="1" colspan="1">0.0001<xref ref-type="fn" rid="brb3936-note-0006">b</xref>
</td><td align="left" rowspan="1" colspan="1">0.681</td><td align="left" rowspan="1" colspan="1">0.849</td><td align="left" rowspan="1" colspan="1">27.5</td><td align="left" rowspan="1" colspan="1">0.902</td><td align="left" rowspan="1" colspan="1">0.541</td></tr><tr><td align="left" rowspan="1" colspan="1">1,25(OH)2 D3</td><td align="left" rowspan="1" colspan="1">0.5</td><td align="left" rowspan="1" colspan="1">0.05</td><td align="left" rowspan="1" colspan="1">1.000</td><td align="left" rowspan="1" colspan="1">0.396</td><td align="left" rowspan="1" colspan="1">0.604</td><td align="left" rowspan="1" colspan="1">&#x02014;</td><td align="left" rowspan="1" colspan="1">&#x02014;</td><td align="left" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" rowspan="3" colspan="1">Mild AD vs. HS</td><td align="left" rowspan="1" colspan="1">MMSE</td><td align="left" rowspan="1" colspan="1">0.993</td><td align="left" rowspan="1" colspan="1">0.01</td><td align="left" rowspan="1" colspan="1">0.0001<xref ref-type="fn" rid="brb3936-note-0006">b</xref>
</td><td align="left" rowspan="1" colspan="1">0.979</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">27.5</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">0.984</td></tr><tr><td align="left" rowspan="1" colspan="1">25 (OH)D3</td><td align="left" rowspan="1" colspan="1">0.815</td><td align="left" rowspan="1" colspan="1">0.04</td><td align="left" rowspan="1" colspan="1">0.0001<xref ref-type="fn" rid="brb3936-note-0006">b</xref>
</td><td align="left" rowspan="1" colspan="1">0.736</td><td align="left" rowspan="1" colspan="1">0.895</td><td align="left" rowspan="1" colspan="1">25.5</td><td align="left" rowspan="1" colspan="1">0.927</td><td align="left" rowspan="1" colspan="1">0.574</td></tr><tr><td align="left" rowspan="1" colspan="1">1,25(OH)2 D3</td><td align="left" rowspan="1" colspan="1">0.41</td><td align="left" rowspan="1" colspan="1">0.06</td><td align="left" rowspan="1" colspan="1">0.124</td><td align="left" rowspan="1" colspan="1">0.293</td><td align="left" rowspan="1" colspan="1">0.527</td><td align="left" rowspan="1" colspan="1">&#x02014;</td><td align="left" rowspan="1" colspan="1">&#x02014;</td><td align="left" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" rowspan="3" colspan="1">Moderate AD vs. HS</td><td align="left" rowspan="1" colspan="1">MMSE</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0.0001<xref ref-type="fn" rid="brb3936-note-0006">b</xref>
</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">22</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">25 (OH)D3</td><td align="left" rowspan="1" colspan="1">0.812</td><td align="left" rowspan="1" colspan="1">0.04</td><td align="left" rowspan="1" colspan="1">0.0001<xref ref-type="fn" rid="brb3936-note-0006">b</xref>
</td><td align="left" rowspan="1" colspan="1">0.725</td><td align="left" rowspan="1" colspan="1">0.899</td><td align="left" rowspan="1" colspan="1">27.5</td><td align="left" rowspan="1" colspan="1">0.943</td><td align="left" rowspan="1" colspan="1">0.541</td></tr><tr><td align="left" rowspan="1" colspan="1">1,25(OH)2 D3</td><td align="left" rowspan="1" colspan="1">0.472</td><td align="left" rowspan="1" colspan="1">0.06</td><td align="left" rowspan="1" colspan="1">0.645</td><td align="left" rowspan="1" colspan="1">0.351</td><td align="left" rowspan="1" colspan="1">0.593</td><td align="left" rowspan="1" colspan="1">&#x02014;</td><td align="left" rowspan="1" colspan="1">&#x02014;</td><td align="left" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" rowspan="3" colspan="1">Severe AD vs. HS</td><td align="left" rowspan="1" colspan="1">MMSE</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0.0001<xref ref-type="fn" rid="brb3936-note-0006">b</xref>
</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">17</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">25 (OH)D3</td><td align="left" rowspan="1" colspan="1">0.911</td><td align="left" rowspan="1" colspan="1">0.03</td><td align="left" rowspan="1" colspan="1">0.0001<xref ref-type="fn" rid="brb3936-note-0006">b</xref>
</td><td align="left" rowspan="1" colspan="1">0.857</td><td align="left" rowspan="1" colspan="1">0.966</td><td align="left" rowspan="1" colspan="1">20.5</td><td align="left" rowspan="1" colspan="1">0.906</td><td align="left" rowspan="1" colspan="1">0.787</td></tr><tr><td align="left" rowspan="1" colspan="1">1,25(OH)2 D3</td><td align="left" rowspan="1" colspan="1">0.493</td><td align="left" rowspan="1" colspan="1">0.07</td><td align="left" rowspan="1" colspan="1">0.913</td><td align="left" rowspan="1" colspan="1">0.367</td><td align="left" rowspan="1" colspan="1">0.62</td><td align="left" rowspan="1" colspan="1">&#x02014;</td><td align="left" rowspan="1" colspan="1">&#x02014;</td><td align="left" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" rowspan="3" colspan="1">Mild AD vs. Moderate AD</td><td align="left" rowspan="1" colspan="1">MMSE</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0.0001<xref ref-type="fn" rid="brb3936-note-0006">b</xref>
</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">20.5</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">25 (OH)D3</td><td align="left" rowspan="1" colspan="1">0.494</td><td align="left" rowspan="1" colspan="1">0.07</td><td align="left" rowspan="1" colspan="1">0.929</td><td align="left" rowspan="1" colspan="1">0.363</td><td align="left" rowspan="1" colspan="1">0.626</td><td align="left" rowspan="1" colspan="1">&#x02014;</td><td align="left" rowspan="1" colspan="1">&#x02014;</td><td align="left" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" rowspan="1" colspan="1">1,25(OH)2 D3</td><td align="left" rowspan="1" colspan="1">0.566</td><td align="left" rowspan="1" colspan="1">0.07</td><td align="left" rowspan="1" colspan="1">0.327</td><td align="left" rowspan="1" colspan="1">0.436</td><td align="left" rowspan="1" colspan="1">0.695</td><td align="left" rowspan="1" colspan="1">&#x02014;</td><td align="left" rowspan="1" colspan="1">&#x02014;</td><td align="left" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" rowspan="3" colspan="1">Severe AD vs. Mild AD</td><td align="left" rowspan="1" colspan="1">MMSE</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0.0001<xref ref-type="fn" rid="brb3936-note-0006">b</xref>
</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">15.5</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">25 (OH)D3</td><td align="left" rowspan="1" colspan="1">0.661</td><td align="left" rowspan="1" colspan="1">0.06</td><td align="left" rowspan="1" colspan="1">0.019<xref ref-type="fn" rid="brb3936-note-0006">b</xref>
</td><td align="left" rowspan="1" colspan="1">0.538</td><td align="left" rowspan="1" colspan="1">0.785</td><td align="left" rowspan="1" colspan="1">21.5</td><td align="left" rowspan="1" colspan="1">0.341</td><td align="left" rowspan="1" colspan="1">0.969</td></tr><tr><td align="left" rowspan="1" colspan="1">1,25(OH)2 D3</td><td align="left" rowspan="1" colspan="1">0.566</td><td align="left" rowspan="1" colspan="1">0.07</td><td align="left" rowspan="1" colspan="1">0.333</td><td align="left" rowspan="1" colspan="1">0.433</td><td align="left" rowspan="1" colspan="1">0.7</td><td align="left" rowspan="1" colspan="1">&#x02014;</td><td align="left" rowspan="1" colspan="1">&#x02014;</td><td align="left" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" rowspan="3" colspan="1">Severe AD vs. Moderate AD</td><td align="left" rowspan="1" colspan="1">MMSE</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0.0001<xref ref-type="fn" rid="brb3936-note-0006">b</xref>
</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">10.5</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">25 (OH)D3</td><td align="left" rowspan="1" colspan="1">0.675</td><td align="left" rowspan="1" colspan="1">0.07</td><td align="left" rowspan="1" colspan="1">0.014<xref ref-type="fn" rid="brb3936-note-0006">b</xref>
</td><td align="left" rowspan="1" colspan="1">0.546</td><td align="left" rowspan="1" colspan="1">0.804</td><td align="left" rowspan="1" colspan="1">21.5</td><td align="left" rowspan="1" colspan="1">0.314</td><td align="left" rowspan="1" colspan="1">0.969</td></tr><tr><td align="left" rowspan="1" colspan="1">1,25(OH)2 D3</td><td align="left" rowspan="1" colspan="1">0.515</td><td align="left" rowspan="1" colspan="1">0.07</td><td align="left" rowspan="1" colspan="1">0.836</td><td align="left" rowspan="1" colspan="1">0.374</td><td align="left" rowspan="1" colspan="1">0.655</td><td align="left" rowspan="1" colspan="1">&#x02014;</td><td align="left" rowspan="1" colspan="1">&#x02014;</td><td align="left" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" rowspan="3" colspan="1">Total AD vs. HS</td><td align="left" rowspan="1" colspan="1">MMSE</td><td align="left" rowspan="1" colspan="1">0.997</td><td align="left" rowspan="1" colspan="1">0.003</td><td align="left" rowspan="1" colspan="1">0.0001<xref ref-type="fn" rid="brb3936-note-0006">b</xref>
</td><td align="left" rowspan="1" colspan="1">0.992</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">27.5</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">0.984</td></tr><tr><td align="left" rowspan="1" colspan="1">25 (OH)D3</td><td align="left" rowspan="1" colspan="1">0.843</td><td align="left" rowspan="1" colspan="1">0.03</td><td align="left" rowspan="1" colspan="1">0.0001<xref ref-type="fn" rid="brb3936-note-0006">b</xref>
</td><td align="left" rowspan="1" colspan="1">0.782</td><td align="left" rowspan="1" colspan="1">0.904</td><td align="left" rowspan="1" colspan="1">20.5</td><td align="left" rowspan="1" colspan="1">0.741</td><td align="left" rowspan="1" colspan="1">0.787</td></tr><tr><td align="left" rowspan="1" colspan="1">1,25(OH)2 D3</td><td align="left" rowspan="1" colspan="1">0.455</td><td align="left" rowspan="1" colspan="1">0.05</td><td align="left" rowspan="1" colspan="1">0.327</td><td align="left" rowspan="1" colspan="1">0.366</td><td align="left" rowspan="1" colspan="1">0.543</td><td align="left" rowspan="1" colspan="1">&#x02014;</td><td align="left" rowspan="1" colspan="1">&#x02014;</td><td align="left" rowspan="1" colspan="1">&#x02014;</td></tr></tbody></table><table-wrap-foot><fn id="brb3936-note-0004"><p>AUC, area under the ROC curve; CI, confidence interval; <italic>SE</italic>, standard error of AUC.</p></fn><fn id="brb3936-note-0005"><label>a</label><p>Cutoff values at which optimal balance of sensitivity and specificity can be obtained according to Youden's index; Youden's Index can be calculated as the sum of sensitivity plus specificity minus 1 for all possible cutoff points.</p></fn><fn id="brb3936-note-0006"><label>b</label><p>Sig, significance of AUC.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd</copyright-holder></permissions></table-wrap></sec><sec id="brb3936-sec-0016"><label>3.6</label><title>Univariate and multivariate logistic regression analyses</title><p>The prediction values were evaluated for each of MCI and AD groups against HS. Univariate analysis of each predictor alone (Table&#x000a0;<xref rid="brb3936-tbl-0004" ref-type="table-wrap">4</xref>) shows that significant (<italic>p&#x000a0;</italic>=<italic>&#x000a0;</italic>.0001) prediction by age (&#x003b2;&#x000a0;=&#x000a0;+0.133; Wald&#x000a0;=&#x000a0;12.12; OR&#x000a0;=&#x000a0;1.143; CC&#x000a0;=&#x000a0;71%; <italic>p&#x000a0;</italic>=<italic>&#x000a0;</italic>.0001) and gender (&#x003b2;&#x000a0;=&#x000a0;&#x02212;0.944; Wald&#x000a0;=&#x000a0;4.49; OR&#x000a0;=&#x000a0;0.389; CC&#x000a0;=&#x000a0;64%; <italic>p&#x000a0;</italic>=<italic>&#x000a0;</italic>.034) was obtained in moderate AD. These results indicate that for each one unit increase of age (1&#x000a0;year), the odds of disease risk increases by 1.143 (53% probability). In case of gender, women were considered as the reference. In other words, the negative value of &#x003b2; indicates that women have 2.6 (1/0.389&#x000a0;=&#x000a0;2.6) times the risk of the disease than men. Moreover, it can also be seen from Table&#x000a0;<xref rid="brb3936-tbl-0004" ref-type="table-wrap">4</xref> that a significant (<italic>p</italic>&#x000a0;=&#x000a0;.0001) prediction by MMSE was observed in MCI (&#x003b2;&#x000a0;=&#x000a0;&#x02212;1.324, Wald&#x000a0;=&#x000a0;27.86, OR&#x000a0;=&#x000a0;0.266) and mild AD (&#x003b2;&#x000a0;=&#x000a0;&#x02212;2.162, Wald&#x000a0;=&#x000a0;15.22, OR&#x000a0;=&#x000a0;0.115). These results indicate that each unit decrease of MMSE reflects 21% and 13% probability increase in the prediction odds of MCI and mild AD, respectively. Table&#x000a0;<xref rid="brb3936-tbl-0004" ref-type="table-wrap">4</xref> also shows that the higher OR and Wald values were detected for 25(OH)D3 in MCI (&#x003b2;&#x000a0;=&#x000a0;&#x02212;0.146, Wald&#x000a0;=&#x000a0;22.044, OR&#x000a0;=&#x000a0;0.864, 46% probability), mild AD (&#x003b2;&#x000a0;=&#x000a0;&#x02212;0.188, Wald&#x000a0;=&#x000a0;22.744, OR&#x000a0;=&#x000a0;0.829, 45% probability), moderate AD (&#x003b2;&#x000a0;=&#x000a0;&#x02212;0.178, Wald&#x000a0;=&#x000a0;20.04, OR&#x000a0;=&#x000a0;0.837, 46% probability), and severe AD (&#x003b2;&#x000a0;=&#x000a0;&#x02212;0.316, Wald&#x000a0;=&#x000a0;20.821, OR&#x000a0;=&#x000a0;0.729, 42%). These results indicate that each unit decrease of 25(OH)D<sub>3</sub> reflects an increase in the prediction OR (by about 80%) and probability (&#x0003e;40%) rate indicated for each of MCI and AD groups. Multivariate analysis of all predictors combined within each group revealed that only MMSE and 25(OH)D<sub>3</sub> displayed significant prediction of MCI.</p><table-wrap id="brb3936-tbl-0004" xml:lang="en" orientation="portrait" position="float"><label>Table 4</label><caption><p>Logistic regression analyses for the contribution of the individual and combined predictors</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><thead valign="top"><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="2" valign="top" colspan="1"/><th align="left" rowspan="2" valign="top" colspan="1">&#x003b2;</th><th align="left" rowspan="2" valign="top" colspan="1">
<italic>SE</italic>
</th><th align="left" rowspan="2" valign="top" colspan="1">Wald</th><th align="left" rowspan="2" valign="top" colspan="1">Sig.</th><th align="left" rowspan="2" valign="top" colspan="1">OR</th><th align="left" colspan="2" style="border-bottom:solid 1px #000000" valign="top" rowspan="1">OR 95% CI</th><th align="left" rowspan="2" valign="top" colspan="1">CC%</th></tr><tr style="border-bottom:solid 1px #000000"><th align="left" valign="top" rowspan="1" colspan="1">Lower</th><th align="left" valign="top" rowspan="1" colspan="1">Upper</th></tr></thead><tbody><tr><td align="left" colspan="9" rowspan="1">MCI&#x02010;HS</td></tr><tr><td align="left" colspan="9" rowspan="1">A&#x02010;Univariate</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Age</td><td align="left" rowspan="1" colspan="1">0.033</td><td align="left" rowspan="1" colspan="1">0.023</td><td align="left" rowspan="1" colspan="1">1.976</td><td align="left" rowspan="1" colspan="1">0.16</td><td align="left" rowspan="1" colspan="1">1.034</td><td align="left" rowspan="1" colspan="1">0.987</td><td align="left" rowspan="1" colspan="1">1.082</td><td align="left" rowspan="1" colspan="1">57.4</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Gender</td><td align="left" rowspan="1" colspan="1">&#x02212;0.197</td><td align="left" rowspan="1" colspan="1">0.363</td><td align="left" rowspan="1" colspan="1">0.295</td><td align="left" rowspan="1" colspan="1">0.587</td><td align="left" rowspan="1" colspan="1">0.821</td><td align="left" rowspan="1" colspan="1">0.403</td><td align="left" rowspan="1" colspan="1">1.672</td><td align="left" rowspan="1" colspan="1">52.5</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">MMSE</td><td align="left" rowspan="1" colspan="1">&#x02212;1.324</td><td align="left" rowspan="1" colspan="1">0.251</td><td align="left" rowspan="1" colspan="1">27.858</td><td align="left" rowspan="1" colspan="1">0.0001*</td><td align="left" rowspan="1" colspan="1">0.266</td><td align="left" rowspan="1" colspan="1">0.163</td><td align="left" rowspan="1" colspan="1">0.435</td><td align="left" rowspan="1" colspan="1">90.2</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">25 (OH)D3</td><td align="left" rowspan="1" colspan="1">&#x02212;0.146</td><td align="left" rowspan="1" colspan="1">0.031</td><td align="left" rowspan="1" colspan="1">22.044</td><td align="left" rowspan="1" colspan="1">0.0001*</td><td align="left" rowspan="1" colspan="1">0.864</td><td align="left" rowspan="1" colspan="1">0.813</td><td align="left" rowspan="1" colspan="1">0.918</td><td align="left" rowspan="1" colspan="1">70.2</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">1,25(OH)2 D3</td><td align="left" rowspan="1" colspan="1">0.005</td><td align="left" rowspan="1" colspan="1">0.011</td><td align="left" rowspan="1" colspan="1">0.251</td><td align="left" rowspan="1" colspan="1">0.616</td><td align="left" rowspan="1" colspan="1">1.005</td><td align="left" rowspan="1" colspan="1">0.985</td><td align="left" rowspan="1" colspan="1">1.026</td><td align="left" rowspan="1" colspan="1">50.8</td></tr><tr><td align="left" colspan="9" rowspan="1">B&#x02010;Multivariate</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">MMSE</td><td align="left" rowspan="1" colspan="1">&#x02212;1.445</td><td align="left" rowspan="1" colspan="1">0.295</td><td align="left" rowspan="1" colspan="1">24.041</td><td align="left" rowspan="1" colspan="1">0.0001*</td><td align="left" rowspan="1" colspan="1">0.236</td><td align="left" rowspan="1" colspan="1">0.132</td><td align="left" rowspan="1" colspan="1">0.42</td><td align="left" rowspan="2" colspan="1">88.5</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">25 (OH)D3</td><td align="left" rowspan="1" colspan="1">&#x02212;0.168</td><td align="left" rowspan="1" colspan="1">0.047</td><td align="left" rowspan="1" colspan="1">12.644</td><td align="left" rowspan="1" colspan="1">0.0001*</td><td align="left" rowspan="1" colspan="1">0.846</td><td align="left" rowspan="1" colspan="1">0.771</td><td align="left" rowspan="1" colspan="1">0.927</td></tr><tr><td align="left" colspan="9" rowspan="1">Mild AD&#x02010;HS</td></tr><tr><td align="left" colspan="9" rowspan="1">A&#x02010;Univariate</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Age</td><td align="left" rowspan="1" colspan="1">0.033</td><td align="left" rowspan="1" colspan="1">0.028</td><td align="left" rowspan="1" colspan="1">1.41</td><td align="left" rowspan="1" colspan="1">0.235</td><td align="left" rowspan="1" colspan="1">1.033</td><td align="left" rowspan="1" colspan="1">0.979</td><td align="left" rowspan="1" colspan="1">1.091</td><td align="left" rowspan="1" colspan="1">61.8</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Gender</td><td align="left" rowspan="1" colspan="1">&#x02212;0.509</td><td align="left" rowspan="1" colspan="1">0.408</td><td align="left" rowspan="1" colspan="1">1.557</td><td align="left" rowspan="1" colspan="1">0.212</td><td align="left" rowspan="1" colspan="1">0.601</td><td align="left" rowspan="1" colspan="1">0.27</td><td align="left" rowspan="1" colspan="1">1.337</td><td align="left" rowspan="1" colspan="1">59.8</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">MMSE</td><td align="left" rowspan="1" colspan="1">&#x02212;2.162</td><td align="left" rowspan="1" colspan="1">0.554</td><td align="left" rowspan="1" colspan="1">15.22</td><td align="left" rowspan="1" colspan="1">0.0001*</td><td align="left" rowspan="1" colspan="1">0.115</td><td align="left" rowspan="1" colspan="1">0.039</td><td align="left" rowspan="1" colspan="1">0.341</td><td align="left" rowspan="1" colspan="1">96.1</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">25 (OH)D3</td><td align="left" rowspan="1" colspan="1">&#x02212;0.188</td><td align="left" rowspan="1" colspan="1">0.039</td><td align="left" rowspan="1" colspan="1">22.744</td><td align="left" rowspan="1" colspan="1">0.0001*</td><td align="left" rowspan="1" colspan="1">0.829</td><td align="left" rowspan="1" colspan="1">0.767</td><td align="left" rowspan="1" colspan="1">0.895</td><td align="left" rowspan="1" colspan="1">71.6</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">1,25(OH)2 D3</td><td align="left" rowspan="1" colspan="1">0.021</td><td align="left" rowspan="1" colspan="1">0.013</td><td align="left" rowspan="1" colspan="1">2.578</td><td align="left" rowspan="1" colspan="1">0.108</td><td align="left" rowspan="1" colspan="1">1.021</td><td align="left" rowspan="1" colspan="1">0.995</td><td align="left" rowspan="1" colspan="1">1.048</td><td align="left" rowspan="1" colspan="1">61.8</td></tr><tr><td align="left" colspan="9" rowspan="1">Moderate AD&#x02010;HS</td></tr><tr><td align="left" colspan="9" rowspan="1">A&#x02010;Univariate</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Age</td><td align="left" rowspan="1" colspan="1">0.133</td><td align="left" rowspan="1" colspan="1">0.038</td><td align="left" rowspan="1" colspan="1">12.119</td><td align="left" rowspan="1" colspan="1">0.0001*</td><td align="left" rowspan="1" colspan="1">1.143</td><td align="left" rowspan="1" colspan="1">1.06</td><td align="left" rowspan="1" colspan="1">1.231</td><td align="left" rowspan="1" colspan="1">70.8</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Gender</td><td align="left" rowspan="1" colspan="1">&#x02212;0.944</td><td align="left" rowspan="1" colspan="1">0.446</td><td align="left" rowspan="1" colspan="1">4.492</td><td align="left" rowspan="1" colspan="1">0.034*</td><td align="left" rowspan="1" colspan="1">0.389</td><td align="left" rowspan="1" colspan="1">0.162</td><td align="left" rowspan="1" colspan="1">0.931</td><td align="left" rowspan="1" colspan="1">63.5</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">MMSE</td><td align="left" rowspan="1" colspan="1">&#x02212;0.053</td><td align="left" rowspan="1" colspan="1">846.038</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0.992</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">100</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">25 (OH)D3</td><td align="left" rowspan="1" colspan="1">&#x02212;0.178</td><td align="left" rowspan="1" colspan="1">0.04</td><td align="left" rowspan="1" colspan="1">20.04</td><td align="left" rowspan="1" colspan="1">0.0001*</td><td align="left" rowspan="1" colspan="1">0.837</td><td align="left" rowspan="1" colspan="1">0.774</td><td align="left" rowspan="1" colspan="1">0.905</td><td align="left" rowspan="1" colspan="1">75</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">1,25(OH)2 D3</td><td align="left" rowspan="1" colspan="1">0.008</td><td align="left" rowspan="1" colspan="1">0.016</td><td align="left" rowspan="1" colspan="1">0.256</td><td align="left" rowspan="1" colspan="1">0.613</td><td align="left" rowspan="1" colspan="1">1.008</td><td align="left" rowspan="1" colspan="1">0.978</td><td align="left" rowspan="1" colspan="1">1.039</td><td align="left" rowspan="1" colspan="1">63.5</td></tr><tr><td align="left" colspan="9" rowspan="1">Severe AD&#x02010;HS</td></tr><tr><td align="left" colspan="9" rowspan="1">A&#x02010;Univariate</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Age</td><td align="left" rowspan="1" colspan="1">0.048</td><td align="left" rowspan="1" colspan="1">0.029</td><td align="left" rowspan="1" colspan="1">2.628</td><td align="left" rowspan="1" colspan="1">0.105</td><td align="left" rowspan="1" colspan="1">1.049</td><td align="left" rowspan="1" colspan="1">0.99</td><td align="left" rowspan="1" colspan="1">1.111</td><td align="left" rowspan="1" colspan="1">66.7</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Gender</td><td align="left" rowspan="1" colspan="1">&#x02212;0.811</td><td align="left" rowspan="1" colspan="1">0.452</td><td align="left" rowspan="1" colspan="1">3.215</td><td align="left" rowspan="1" colspan="1">0.073</td><td align="left" rowspan="1" colspan="1">0.444</td><td align="left" rowspan="1" colspan="1">0.183</td><td align="left" rowspan="1" colspan="1">1.078</td><td align="left" rowspan="1" colspan="1">65.6</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">MMSE</td><td align="left" rowspan="1" colspan="1">&#x02212;0.456</td><td align="left" rowspan="1" colspan="1">397.131</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0.995</td><td align="left" rowspan="1" colspan="1">0.086</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">100</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">25 (OH)D3</td><td align="left" rowspan="1" colspan="1">&#x02212;0.316</td><td align="left" rowspan="1" colspan="1">0.069</td><td align="left" rowspan="1" colspan="1">20.821</td><td align="left" rowspan="1" colspan="1">0.0001*</td><td align="left" rowspan="1" colspan="1">0.729</td><td align="left" rowspan="1" colspan="1">0.636</td><td align="left" rowspan="1" colspan="1">0.835</td><td align="left" rowspan="1" colspan="1">78.5</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">1,25(OH)2 D3</td><td align="left" rowspan="1" colspan="1">0.012</td><td align="left" rowspan="1" colspan="1">0.013</td><td align="left" rowspan="1" colspan="1">0.86</td><td align="left" rowspan="1" colspan="1">0.354</td><td align="left" rowspan="1" colspan="1">1.012</td><td align="left" rowspan="1" colspan="1">0.987</td><td align="left" rowspan="1" colspan="1">1.037</td><td align="left" rowspan="1" colspan="1">67.7</td></tr><tr><td align="left" colspan="9" rowspan="1">All participants</td></tr><tr><td align="left" colspan="9" rowspan="1">A&#x02010;Univariate</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Age</td><td align="left" rowspan="1" colspan="1">0.059</td><td align="left" rowspan="1" colspan="1">0.021</td><td align="left" rowspan="1" colspan="1">7.502</td><td align="left" rowspan="1" colspan="1">0.006*</td><td align="left" rowspan="1" colspan="1">1.06</td><td align="left" rowspan="1" colspan="1">1.017</td><td align="left" rowspan="1" colspan="1">1.106</td><td align="left" rowspan="1" colspan="1">62.1</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Gender</td><td align="left" rowspan="1" colspan="1">&#x02212;0.735</td><td align="left" rowspan="1" colspan="1">0.326</td><td align="left" rowspan="1" colspan="1">5.087</td><td align="left" rowspan="1" colspan="1">0.024*</td><td align="left" rowspan="1" colspan="1">0.48</td><td align="left" rowspan="1" colspan="1">0.253</td><td align="left" rowspan="1" colspan="1">0.908</td><td align="left" rowspan="1" colspan="1">63.9</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">MMSE</td><td align="left" rowspan="1" colspan="1">&#x02212;0.162</td><td align="left" rowspan="1" colspan="1">0.554</td><td align="left" rowspan="1" colspan="1">15.22</td><td align="left" rowspan="1" colspan="1">0.0001*</td><td align="left" rowspan="1" colspan="1">0.115</td><td align="left" rowspan="1" colspan="1">0.039</td><td align="left" rowspan="1" colspan="1">0.341</td><td align="left" rowspan="1" colspan="1">97.6</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">25(OH)D3</td><td align="left" rowspan="1" colspan="1">&#x02212;0.213</td><td align="left" rowspan="1" colspan="1">0.033</td><td align="left" rowspan="1" colspan="1">41.013</td><td align="left" rowspan="1" colspan="1">0.0001*</td><td align="left" rowspan="1" colspan="1">0.808</td><td align="left" rowspan="1" colspan="1">0.757</td><td align="left" rowspan="1" colspan="1">0.863</td><td align="left" rowspan="1" colspan="1">79.9</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">1,25(OH)2 D3</td><td align="left" rowspan="1" colspan="1">0.013</td><td align="left" rowspan="1" colspan="1">0.01</td><td align="left" rowspan="1" colspan="1">1.635</td><td align="left" rowspan="1" colspan="1">0.201</td><td align="left" rowspan="1" colspan="1">1.013</td><td align="left" rowspan="1" colspan="1">0.993</td><td align="left" rowspan="1" colspan="1">1.033</td><td align="left" rowspan="1" colspan="1">63.9</td></tr><tr><td align="left" colspan="9" rowspan="1">B&#x02010;Multivariate</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">MMSE</td><td align="left" rowspan="1" colspan="1">&#x02212;2.83</td><td align="left" rowspan="1" colspan="1">1.022</td><td align="left" rowspan="1" colspan="1">7.662</td><td align="left" rowspan="1" colspan="1">0.006*</td><td align="left" rowspan="1" colspan="1">0.059</td><td align="left" rowspan="1" colspan="1">0.008</td><td align="left" rowspan="1" colspan="1">0.438</td><td align="left" rowspan="2" colspan="1">98.2</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">25(OH)D3</td><td align="left" rowspan="1" colspan="1">&#x02212;0.207</td><td align="left" rowspan="1" colspan="1">0.173</td><td align="left" rowspan="1" colspan="1">2.262</td><td align="left" rowspan="1" colspan="1">0.0018*</td><td align="left" rowspan="1" colspan="1">0.813</td><td align="left" rowspan="1" colspan="1">0.579</td><td align="left" rowspan="1" colspan="1">1.141</td></tr></tbody></table><table-wrap-foot><fn id="brb3936-note-0007"><p>&#x003b2;: Logistic regression coefficient; CC%: correct classification %; CI: confidence interval; OR: Odd ratio (Exponent of &#x003b2;), Sig: Logistic Regression <italic>p</italic> values for Wald. Only significant variables are retained in the B. Disease groups were tested against HS. Predictor power was evaluated in MCI and AD tested against HS.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd</copyright-holder></permissions></table-wrap><p>Table&#x000a0;<xref rid="brb3936-tbl-0004" ref-type="table-wrap">4</xref> shows that univariate analysis of all groups collectively revealed the significant contribution of all the examined predictors. The maximum Wald (41.013) and CC% (97.6%) were exhibited by 25(OH)D<sub>3</sub> and MMSE, respectively. Again, multivariate analysis showed that only combined MMSE and 25(OH)D<sub>3</sub> retained their significant prediction and exhibited 98% accuracy in distinguishing and predicting the diseases.</p></sec></sec><sec id="brb3936-sec-0017"><label>4</label><title>DISCUSSION</title><p>The present results show that MMSE and 25(OH)D<sub>3</sub> (but not 1,25(OH)<sub>2</sub>D<sub>3</sub>) were decreased in MCI and various stages of AD. Although MMSE is one of the most widely used tools in the evaluation of cognitive status, there is still a debate about its diagnostic accuracy. Some studies have reported that MMSE lacks diagnostic specificity and has limited diagnostic accuracy, particularly for distinguishing between normal cognition and MCI, and MCI from demential patients with AD (Chapman et&#x000a0;al., <xref rid="brb3936-bib-0012" ref-type="ref">2016</xref>) and in measuring the progression of Alzheimer's disease (Clark et&#x000a0;al., <xref rid="brb3936-bib-0014" ref-type="ref">1999</xref>). On the other hand, MMSE has been regarded as a good first step in the evaluation of cognitive status and effectively separating those with mild AD from normal aging and MCI (Benson, Slavin, Tran, Petrella, &#x00026; Doraiswamy, <xref rid="brb3936-bib-0008" ref-type="ref">2005</xref>). It has high test&#x02013;retest reliability values, ranging from 0.79 to 0.99 (Folstein et&#x000a0;al., <xref rid="brb3936-bib-0025" ref-type="ref">1975</xref>). MMSE had also been reported to predict converters to AD (Devanand et&#x000a0;al., <xref rid="brb3936-bib-0017" ref-type="ref">2008</xref>; Palmqvist et&#x000a0;al., <xref rid="brb3936-bib-0043" ref-type="ref">2012</xref>). The present study highlights the value of MMSE and 25(OH)D<sub>3</sub> in the differential diagnosis and prediction of MCI, mild AD, moderate AD, and severe AD at a sensitivity rate &#x0003e;80. The differences among the results reported for MMSE could be attributed to the analyses approach such as selection of the cutoff values, and the patients&#x02019; cultural, education, and demographic specificities. It is also noteworthy to mention that MMSE could be influenced by changes that could accompany dementia. A low level of the MMSE score is associated with low plasma phosphate (Haglin &#x00026; Backman, <xref rid="brb3936-bib-0029" ref-type="ref">2016</xref>).</p><p>Vitamin D3 is produced in the skin from 7&#x02010;dehydrocholesterol under the influence of UV light. Vitamin D is metabolized first to 25(OH)D<sub>3</sub> in the liver, then undergoes 1&#x003b1;&#x02010; hydroxylation to the hormonal form 1,25(OH)<sub>2</sub>D<sub>3</sub> in the kidney (Bikle, <xref rid="brb3936-bib-0009" ref-type="ref">2014</xref>). The relation of 25(OH)D<sub>3</sub> and 1,25(OH)<sub>2</sub>D<sub>3</sub> is farther than that between a substrate and its product. 25(OH)D<sub>3</sub> and 1,25(OH)2D<sub>3</sub> are synthesized, regulated, and changed differently in variable diseases. While 25(OH)D<sub>3</sub> is mainly synthesized by CYP2R1 (endoplasmic reticulum), CYP27B1 (mitochondrial) is the main enzyme involved in the synthesis of 1,25(OH)<sub>2</sub>D<sub>3</sub>. The independence of 1,25(OH)<sub>2</sub>D<sub>3</sub> concentration from that of its precursor (25(OH)D<sub>3</sub>) is expected and could be attributed to their different kinetics and regulation. While 25(OH)D<sub>3</sub> (prehormone) concentration is increased by a high dose of vitamin D, plasma levels of 1,25(OH)<sub>2</sub>D<sub>3</sub> (adaptive hormone) appeared to fall with increasing doses of vitamin D, presumably because the 1&#x02010;hydroxylase system is shut down (Jones, Strugnell, &#x00026; DeLuca, <xref rid="brb3936-bib-0034" ref-type="ref">1998</xref>). 1,25(OH)<sub>2</sub>D<sub>3</sub> inhibits its own synthesis and that of its precursor 25(OH)D<sub>3</sub> (Bell, Shaw, &#x00026; Turner, <xref rid="brb3936-bib-0007" ref-type="ref">1984</xref>). It has been reported that 1,25(OH)<sub>2</sub>D<sub>3</sub> kinetics do not change by aging in healthy men and women (Eastell et&#x000a0;al., <xref rid="brb3936-bib-0022" ref-type="ref">1991</xref>; Halloran, Portale, Lonergan, &#x00026; Morris, <xref rid="brb3936-bib-0030" ref-type="ref">1990</xref>). The production of 1,25(OH)2D3 could take place extrarenally and regulated endocrinologically. It has been reported that 1,25(OH)<sub>2</sub>D<sub>3</sub> is increased by parathyroid hormone (Eastell et&#x000a0;al., <xref rid="brb3936-bib-0022" ref-type="ref">1991</xref>) and cytokines, including TNF (Bikle &#x00026; Vitamin, <xref rid="brb3936-bib-0009" ref-type="ref">2014</xref>). However, serum 25(OH)D3 is negatively correlated with TNF&#x003b1;, IL&#x02010;1&#x003b2; or IL&#x02010;6 levels in healthy subjects and patients with MCI, but positively with late&#x02010;onset AD (Dursun et&#x000a0;al., <xref rid="brb3936-bib-0019" ref-type="ref">2016</xref>). As TNF is increased in AD (Gezen&#x02010;Ak et&#x000a0;al., <xref rid="brb3936-bib-0027" ref-type="ref">2013</xref>), it is possible that the increased TNF&#x003b1; is responsible for the decreased 25(OH)D<sub>3</sub>. These mechanisms could play a role in maintaining 1,25(OH)<sub>2</sub>D<sub>3</sub> level against reduced 25(OH)D<sub>3</sub>.</p><p>The serum vitamin D level is associated with its activity in the brain. Serum 25(OH)D<sub>3</sub> concentration is correlated with regional cerebral blood flow (Farid et&#x000a0;al., <xref rid="brb3936-bib-0023" ref-type="ref">2012</xref>), brain volume and gray matter thickness (Brouwer&#x02010;Brolsma et&#x000a0;al., <xref rid="brb3936-bib-0010" ref-type="ref">2015</xref>; Buell et&#x000a0;al., <xref rid="brb3936-bib-0011" ref-type="ref">2010</xref>; Hooshmand, L&#x000f6;kk, &#x00026; Solomon, <xref rid="brb3936-bib-0033" ref-type="ref">2014</xref>) and clearance of aggregated A&#x003b2; in the AD brain (Durk et&#x000a0;al., <xref rid="brb3936-bib-0018" ref-type="ref">2014</xref>; Masoumi, Goldenson, &#x00026; Ghirmai, <xref rid="brb3936-bib-0039" ref-type="ref">2009</xref>; Yu et&#x000a0;al., <xref rid="brb3936-bib-0054" ref-type="ref">2011</xref>). On the other hand, low serum 25(OH)D<sub>3</sub> is associated with neuronal damages (Gezen&#x02010;AK, Yilmazer, &#x00026; Dursun, <xref rid="brb3936-bib-0028" ref-type="ref">2014</xref>), MCI (Annweiler et&#x000a0;al., <xref rid="brb3936-bib-0003" ref-type="ref">2012</xref>), multidomain MCI (Yin et&#x000a0;al., <xref rid="brb3936-bib-0053" ref-type="ref">2015</xref>) and AD (Annweiler et&#x000a0;al., <xref rid="brb3936-bib-0001" ref-type="ref">2015</xref>; Balion, Griffith, &#x00026; Strifler, <xref rid="brb3936-bib-0005" ref-type="ref">2012</xref>; Chei et&#x000a0;al., <xref rid="brb3936-bib-0013" ref-type="ref">2014</xref>; Littlejohns, Henley, &#x00026; Lang, <xref rid="brb3936-bib-0037" ref-type="ref">2014</xref>). The present results showed that 25(OH)D<sub>3</sub> is involved in the decrease of MMSE, and predict MCI, mild AD, and moderate AD. It was the only significant predictor of severe AD. It differentiated the disease from HS at a sensitivity &#x0003e;90%, but exhibited only a poor&#x02013;weak diagnostic power when the evaluation was carried out among the stages of AD. It should be noted that although 25(OH)D<sub>3</sub> was decreased in MCI and AD, no difference was observed between women and men but it predicted a 2.5 times higher incidence of AD in women than in men. This result is in line with that reported 1.5&#x02013;3 times higher incidence of AD in women than the incidence in men (Baum, <xref rid="brb3936-bib-0006" ref-type="ref">2005</xref>). Our results also showed that the decrease of 25(OH) D<sub>3</sub> in patients with MCI and AD was not accompanied by a similar change of 1,25(OH)<sub>2</sub>D<sub>3</sub>; hence, serum 1,25(OH)<sub>2</sub>D<sub>3</sub> concentration did not vary among HS and participants with MCI or AD. No change in 1, 25(OH)<sub>2</sub>D<sub>3</sub> adds to the fact that concentration of 1,25(OH)<sub>2</sub>D<sub>3</sub> is not a reliable marker in AD. Another finding of this study was that serum 1,25(OH)<sub>2</sub>D<sub>3</sub> and 25(OH)D<sub>3</sub> concentrations were not correlated in the HS group. It is noteworthy to mention that while 25(OH)D<sub>3</sub> and 1,25(OH)<sub>2</sub>D<sub>3</sub> concentrations were not correlated in men with AD, they were positively correlated in women patients with AD. These results may be associated with high incidence of AD in women and suggest gender differences. It could also result from possible limitation of 1,25(OH)<sub>2</sub>D<sub>3</sub> synthesis from 25(OH)D<sub>3</sub> in these patients. These results could suggest that vitamin D supplementation may be useful to patients with AD, especially in women, based on a positive correlation between serum 25(OH)D3 and 1,25(OH)2D3 in patients with AD.</p></sec><sec id="brb3936-sec-0018"><label>5</label><title>CONCLUSION</title><p>MMSE and 25(OH)D<sub>3</sub> are excellent&#x02013;perfect predictors and diagnostic instruments for MCI and AD. The present study highlights the value of the combination of MMSE and 25(OH)D<sub>3</sub> (but not 1,25(OH)<sub>2</sub>D<sub>3</sub>) as it provides an overall 98% prediction success rate. These results suggest that MMSE and 25(OH)D<sub>3</sub> could support the clinical diagnosis of MCI and the mild, moderate, and severe stages of AD.</p></sec><sec id="brb3936-sec-0020"><title>CONFLICT OF INTEREST</title><p>The authors declare no conflicts of interests.</p></sec></body><back><ack id="brb3936-sec-0019"><title>ACKNOWLEDGMENT</title><p>This study was supported by a Grant&#x02010;in&#x02010;Aid (No. 15K08631) from the Ministry of Education, Science, Sport, and Culture of Japan. We thank Dr. Hande &#x0015e;enol, lecturer at Department of Biostatistics, Faculty of Medicine, Pamukkale University for her contribution to the statistical analysis.</p></ack><ref-list content-type="cited-references" id="brb3936-bibl-0001"><title>REFERENCES</title><ref id="brb3936-bib-0001"><mixed-citation publication-type="journal" id="brb3936-cit-0001">
<string-name>
<surname>Annweiler</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Dursun</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<surname>F&#x000e9;ron</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>Gezen&#x02010;Ak</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<surname>Kalueff</surname>, <given-names>A. V.</given-names>
</string-name>, <string-name>
<surname>Littlejohns</surname>, <given-names>T.</given-names>
</string-name>, &#x02026; <string-name>
<surname>Yilmazer</surname>, <given-names>S.</given-names>
</string-name> (<year>2015</year>). <article-title>Vitamin D and cognition in older adults&#x02019;: Updated international recommendations</article-title>. <source>Journal of Internal Medicine</source>, <volume>277</volume>, <fpage>45</fpage>&#x02013;<lpage>57</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/joim.12279">https://doi.org/10.1111/joim.12279</ext-link>
<pub-id pub-id-type="pmid">24995480</pub-id></mixed-citation></ref><ref id="brb3936-bib-0002"><mixed-citation publication-type="journal" id="brb3936-cit-0002">
<string-name>
<surname>Annweiler</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Fantino</surname>, <given-names>B.</given-names>
</string-name>, <string-name>
<surname>Le Gall</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<surname>Schott</surname>, <given-names>A. M.</given-names>
</string-name>, <string-name>
<surname>Berrut</surname>, <given-names>G.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Beauchet</surname>, <given-names>O.</given-names>
</string-name> (<year>2011</year>). <article-title>Severe vitamin D deficiency is associated with advanced&#x02010;stage dementia in geriatric inpatients</article-title>. <source>Journal of the American Geriatric Society</source>, <volume>59</volume>, <fpage>169</fpage>&#x02013;<lpage>171</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/j.1532-5415.2010.03166.x">https://doi.org/10.1111/j.1532-5415.2010.03166.x</ext-link>
</mixed-citation></ref><ref id="brb3936-bib-0003"><mixed-citation publication-type="journal" id="brb3936-cit-0003">
<string-name>
<surname>Annweiler</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Fantino</surname>, <given-names>B.</given-names>
</string-name>, <string-name>
<surname>Schott</surname>, <given-names>A. M.</given-names>
</string-name>, <string-name>
<surname>Krolak&#x02010;Salmon</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<surname>Allali</surname>, <given-names>G.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Beauchet</surname>, <given-names>O.</given-names>
</string-name> (<year>2012</year>). <article-title>Vitamin D insufficiency and mild cognitive impairment: Cross&#x02010;sectional association</article-title>. <source>European Journal of Neurology</source>, <volume>19</volume>, <fpage>1023</fpage>&#x02013;<lpage>1029</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/j.1468-1331.2012.03675.x">https://doi.org/10.1111/j.1468-1331.2012.03675.x</ext-link>
<pub-id pub-id-type="pmid">22339714</pub-id></mixed-citation></ref><ref id="brb3936-bib-0004"><mixed-citation publication-type="journal" id="brb3936-cit-0004">
<string-name>
<surname>Annweiler</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Schott</surname>, <given-names>A. M.</given-names>
</string-name>, <string-name>
<surname>Rolland</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Blain</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Herrmann</surname>, <given-names>F. R.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Beauchet</surname>, <given-names>O.</given-names>
</string-name> (<year>2010</year>). <article-title>Dietary intake of vitamin D and cognition in older women: A large population&#x02010;based study</article-title>. <source>Neurology</source>, <volume>75</volume>, <fpage>1810</fpage>&#x02013;<lpage>1816</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1212/WNL.0b013e3181fd6352">https://doi.org/10.1212/WNL.0b013e3181fd6352</ext-link>
<pub-id pub-id-type="pmid">21079183</pub-id></mixed-citation></ref><ref id="brb3936-bib-0005"><mixed-citation publication-type="journal" id="brb3936-cit-0005">
<string-name>
<surname>Balion</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Griffith</surname>, <given-names>L. E.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Strifler</surname>, <given-names>L.</given-names>
</string-name> (<year>2012</year>). <article-title>Vitamin D, cognition, and dementia: A systematic review and meta&#x02010;analysis</article-title>. <source>Neurology</source>, <volume>79</volume>, <fpage>1397</fpage>&#x02013;<lpage>1405</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1212/WNL.0b013e31826c197f">https://doi.org/10.1212/WNL.0b013e31826c197f</ext-link>
<pub-id pub-id-type="pmid">23008220</pub-id></mixed-citation></ref><ref id="brb3936-bib-0006"><mixed-citation publication-type="journal" id="brb3936-cit-0006">
<string-name>
<surname>Baum</surname>, <given-names>L. W.</given-names>
</string-name> (<year>2005</year>). <article-title>Gender, hormones, and Alzheimer's disease</article-title>. <source>The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences</source>, <volume>60</volume>, <fpage>736</fpage>&#x02013;<lpage>743</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/gerona/60.6.736">https://doi.org/10.1093/gerona/60.6.736</ext-link>
</mixed-citation></ref><ref id="brb3936-bib-0007"><mixed-citation publication-type="journal" id="brb3936-cit-0007">
<string-name>
<surname>Bell</surname>, <given-names>N. H.</given-names>
</string-name>, <string-name>
<surname>Shaw</surname>, <given-names>S.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Turner</surname>, <given-names>R. T.</given-names>
</string-name> (<year>1984</year>). <article-title>Evidence that 1,25&#x02010;dihydroxyvitamin D3 inhibits the hepatic production of 25&#x02010;hydroxyvitamin D in man</article-title>. <source>The Journal of Clinical Investigation</source>, <volume>74</volume>, <fpage>1540</fpage>&#x02013;<lpage>1544</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1172/JCI111568">https://doi.org/10.1172/JCI111568</ext-link>
<pub-id pub-id-type="pmid">6332830</pub-id></mixed-citation></ref><ref id="brb3936-bib-0008"><mixed-citation publication-type="journal" id="brb3936-cit-0008">
<string-name>
<surname>Benson</surname>, <given-names>A. D.</given-names>
</string-name>, <string-name>
<surname>Slavin</surname>, <given-names>M. J.</given-names>
</string-name>, <string-name>
<surname>Tran</surname>, <given-names>T.&#x02010;T.</given-names>
</string-name>, <string-name>
<surname>Petrella</surname>, <given-names>J. R.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Doraiswamy</surname>, <given-names>P. M.</given-names>
</string-name> (<year>2005</year>). <article-title>Screening for early Alzheimer's Disease: Is there still a role for the mini&#x02010;mental state examination?</article-title>
<source>Primary Care Companion to the Journal of Clinical Psychiatry</source>, <volume>7</volume>(<issue>2</issue>), <fpage>62</fpage>&#x02013;<lpage>69</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.4088/PCC.v07n0204">https://doi.org/10.4088/PCC.v07n0204</ext-link>
</mixed-citation></ref><ref id="brb3936-bib-0009"><mixed-citation publication-type="journal" id="brb3936-cit-0009">
<string-name>
<surname>Bikle</surname>, <given-names>D. D.</given-names>
</string-name> (<year>2014</year>). <article-title>Vitamin D metabolism, mechanism of action, and clinical applications</article-title>. <source>Chemistry &#x00026; Biology</source>, <volume>21</volume>, <fpage>319</fpage>&#x02013;<lpage>329</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.chembiol.2013.12.016">https://doi.org/10.1016/j.chembiol.2013.12.016</ext-link>
<pub-id pub-id-type="pmid">24529992</pub-id></mixed-citation></ref><ref id="brb3936-bib-0010"><mixed-citation publication-type="journal" id="brb3936-cit-0010">
<string-name>
<surname>Brouwer&#x02010;Brolsma</surname>, <given-names>E. M.</given-names>
</string-name>, <string-name>
<surname>van der Zwaluw</surname>, <given-names>N. L.</given-names>
</string-name>, <string-name>
<surname>van Wijngaarden</surname>, <given-names>J. P.</given-names>
</string-name>, <string-name>
<surname>Dhonukshe&#x02010;Rutten</surname>, <given-names>R. A.</given-names>
</string-name>, <string-name>
<surname>Veld</surname>, <given-names>P. H.</given-names>
</string-name>, <string-name>
<surname>Feskens</surname>, <given-names>E. J.</given-names>
</string-name>, &#x02026; <string-name>
<surname>de Groot</surname>, <given-names>L. C.</given-names>
</string-name> (<year>2015</year>). <article-title>Higher Serum 25&#x02010;Hydroxyvitamin D and lower plasma glucose are associated with larger gray matter volume but not with white matter or total brain volume in Dutch Community&#x02010;dwelling older adults</article-title>. <source>Journal of Nutrition</source>, <volume>145</volume>, <fpage>1817</fpage>&#x02013;<lpage>1823</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3945/jn.115.214197">https://doi.org/10.3945/jn.115.214197</ext-link>
<pub-id pub-id-type="pmid">26136594</pub-id></mixed-citation></ref><ref id="brb3936-bib-0011"><mixed-citation publication-type="journal" id="brb3936-cit-0011">
<string-name>
<surname>Buell</surname>, <given-names>J. S.</given-names>
</string-name>, <string-name>
<surname>Dawson&#x02010;Hughes</surname>, <given-names>B.</given-names>
</string-name>, <string-name>
<surname>Scott</surname>, <given-names>T. M.</given-names>
</string-name>, <string-name>
<surname>Weiner</surname>, <given-names>D. E.</given-names>
</string-name>, <string-name>
<surname>Dallal</surname>, <given-names>G. E.</given-names>
</string-name>, <string-name>
<surname>Qui</surname>, <given-names>W. Q.</given-names>
</string-name>, &#x02026; <string-name>
<surname>Bhadelia</surname>, <given-names>R. A.</given-names>
</string-name> (<year>2010</year>). <article-title>25&#x02010;Hydroxyvitamin D, dementia, and cerebrovascular pathology in elders receiving home services</article-title>. <source>Neurology</source>, <volume>74</volume>, <fpage>18</fpage>&#x02013;<lpage>26</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1212/WNL.0b013e3181beecb7">https://doi.org/10.1212/WNL.0b013e3181beecb7</ext-link>
<pub-id pub-id-type="pmid">19940273</pub-id></mixed-citation></ref><ref id="brb3936-bib-0012"><mixed-citation publication-type="journal" id="brb3936-cit-0012">
<string-name>
<surname>Chapman</surname>, <given-names>K. R.</given-names>
</string-name>, <string-name>
<surname>Bing&#x02010;Canar</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Alosco</surname>, <given-names>M. L.</given-names>
</string-name>, <string-name>
<surname>Steinberg</surname>, <given-names>E. G.</given-names>
</string-name>, <string-name>
<surname>Martin</surname>, <given-names>B.</given-names>
</string-name>, <string-name>
<surname>Chaisson</surname>, <given-names>C.</given-names>
</string-name>, &#x02026; <string-name>
<surname>Stern</surname>, <given-names>R. A.</given-names>
</string-name> (<year>2016</year>). <article-title>Mini mental state examination and logical memory scores for entry into Alzheimer's disease trials</article-title>. <source>Alzheimer's Research &#x00026; Therapy</source>, <volume>8</volume>, <fpage>9</fpage>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/s13195-016-0176-z">https://doi.org/10.1186/s13195-016-0176-z</ext-link>
</mixed-citation></ref><ref id="brb3936-bib-0013"><mixed-citation publication-type="journal" id="brb3936-cit-0013">
<string-name>
<surname>Chei</surname>, <given-names>C. L.</given-names>
</string-name>, <string-name>
<surname>Raman</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<surname>Yin</surname>, <given-names>Z. X.</given-names>
</string-name>, <string-name>
<surname>Shi</surname>, <given-names>X. M.</given-names>
</string-name>, <string-name>
<surname>Zeng</surname>, <given-names>Y.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Matchar</surname>, <given-names>D. B.</given-names>
</string-name> (<year>2014</year>). <article-title>Vitamin D levels and cognition in elderly adults in China</article-title>. <source>Journal of the American Geriatric Society</source>, <volume>62</volume>, <fpage>2125</fpage>&#x02013;<lpage>2129</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/jgs.13082">https://doi.org/10.1111/jgs.13082</ext-link>
</mixed-citation></ref><ref id="brb3936-bib-0014"><mixed-citation publication-type="journal" id="brb3936-cit-0014">
<string-name>
<surname>Clark</surname>, <given-names>C. M.</given-names>
</string-name>, <string-name>
<surname>Sheppard</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Fillenbaum</surname>, <given-names>G. G.</given-names>
</string-name>, <string-name>
<surname>Galasko</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<surname>Morris</surname>, <given-names>J. C.</given-names>
</string-name>, <string-name>
<surname>Koss</surname>, <given-names>E.</given-names>
</string-name>, &#x02026; <string-name>
<surname>Heyman</surname>, <given-names>A.</given-names>
</string-name> (<year>1999</year>). <article-title>Variability in annual mini&#x02010;mental state examination score in patients with probable Alzheimer disease: A clinical perspective of data from the Consortium to Establish a Registry for Alzheimer's Disease</article-title>. <source>Archives of Neurology</source>, <volume>56</volume>(<issue>7</issue>), <fpage>857</fpage>&#x02013;<lpage>862</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1001/archneur.56.7.857">https://doi.org/10.1001/archneur.56.7.857</ext-link>
<pub-id pub-id-type="pmid">10404988</pub-id></mixed-citation></ref><ref id="brb3936-bib-0015"><mixed-citation publication-type="journal" id="brb3936-cit-0015">
<string-name>
<surname>Creavin</surname>, <given-names>S. T.</given-names>
</string-name>, <string-name>
<surname>Wisniewski</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Noel&#x02010;Storr</surname>, <given-names>A. H.</given-names>
</string-name>, <string-name>
<surname>Trevelyan</surname>, <given-names>C. M.</given-names>
</string-name>, <string-name>
<surname>Hampton</surname>, <given-names>T.</given-names>
</string-name>, <string-name>
<surname>Rayment</surname>, <given-names>D.</given-names>
</string-name>, &#x02026; <string-name>
<surname>Patel</surname>, <given-names>A. S.</given-names>
</string-name> (<year>2016</year>). <article-title>Mini&#x02010;Mental State Examination (MMSE) for the detection of dementia in clinically unevaluated people aged 65 and over in community and primary care populations</article-title>. <source>Cochrane Database of Systematic Reviews</source> (<issue>1</issue>), <fpage>CD011145</fpage>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/14651858.cd011145.pub2">https://doi.org/10.1002/14651858.cd011145.pub2</ext-link>
<pub-id pub-id-type="pmid">26760674</pub-id></mixed-citation></ref><ref id="brb3936-bib-0016"><mixed-citation publication-type="journal" id="brb3936-cit-0016">
<string-name>
<surname>Dean</surname>, <given-names>A. J.</given-names>
</string-name>, <string-name>
<surname>Bellgrove</surname>, <given-names>M. A.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Hall</surname>, <given-names>T.</given-names>
</string-name> (<year>2011</year>). <article-title>Effects of vitamin D supplementation on cognitive and emotional functioning in young adults&#x02013;a randomised controlled trial</article-title>. <source>PLoS ONE</source>, <volume>6</volume>, <fpage>e25966</fpage>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0025966">https://doi.org/10.1371/journal.pone.0025966</ext-link>
<pub-id pub-id-type="pmid">22073146</pub-id></mixed-citation></ref><ref id="brb3936-bib-0017"><mixed-citation publication-type="journal" id="brb3936-cit-0017">
<string-name>
<surname>Devanand</surname>, <given-names>D. P.</given-names>
</string-name>, <string-name>
<surname>Liu</surname>, <given-names>X.</given-names>
</string-name>, <string-name>
<surname>Tabert</surname>, <given-names>M. H.</given-names>
</string-name>, <string-name>
<surname>Pradhaban</surname>, <given-names>G.</given-names>
</string-name>, <string-name>
<surname>Cuasay</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<surname>Bell</surname>, <given-names>K.</given-names>
</string-name>, &#x02026; <string-name>
<surname>Pelton</surname>, <given-names>G. H.</given-names>
</string-name> (<year>2008</year>). <article-title>Combining early markers strongly predicts conversion from mild cognitive impairment to Alzheimer's disease</article-title>. <source>Biological Psychiatry</source>, <volume>64</volume>, <fpage>871</fpage>&#x02013;<lpage>879</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.biopsych.2008.06.020">https://doi.org/10.1016/j.biopsych.2008.06.020</ext-link>
<pub-id pub-id-type="pmid">18723162</pub-id></mixed-citation></ref><ref id="brb3936-bib-0018"><mixed-citation publication-type="journal" id="brb3936-cit-0018">
<string-name>
<surname>Durk</surname>, <given-names>M. R.</given-names>
</string-name>, <string-name>
<surname>Han</surname>, <given-names>K.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Chow</surname>, <given-names>E. C.</given-names>
</string-name> (<year>2014</year>). <article-title>1&#x003b1;,25&#x02010;Dihydroxyvitamin D3 reduces cerebral amyloid&#x02010;&#x003b2; accumulation and improves cognition in mouse models of Alzheimer's disease</article-title>. <source>Journal of Neuroscience</source>, <volume>34</volume>, <fpage>7091</fpage>&#x02013;<lpage>7101</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1523/JNEUROSCI.2711-13.2014">https://doi.org/10.1523/JNEUROSCI.2711-13.2014</ext-link>
<pub-id pub-id-type="pmid">24849345</pub-id></mixed-citation></ref><ref id="brb3936-bib-0019"><mixed-citation publication-type="journal" id="brb3936-cit-0019">
<string-name>
<surname>Dursun</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<surname>Alayl&#x00131;o&#x0011f;lu</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Bilgi&#x000e7;</surname>, <given-names>B.</given-names>
</string-name>, <string-name>
<surname>Hana&#x0011f;as&#x00131;</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Lohmann</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<surname>Atasoy</surname>, <given-names>I. L.</given-names>
</string-name>, &#x02026; <string-name>
<surname>Y&#x00131;lmazer</surname>, <given-names>S.</given-names>
</string-name> (<year>2016</year>). <article-title>Vitamin D deficiency might propose a greater risk for ApoE&#x003b5;4 non&#x02010;carrier Alzheimer's disease patients</article-title>. <source>Neurological Sciences</source>, <volume>37</volume>, <fpage>1633</fpage>&#x02013;<lpage>1643</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s10072-016-2647-1">https://doi.org/10.1007/s10072-016-2647-1</ext-link>
<pub-id pub-id-type="pmid">27357856</pub-id></mixed-citation></ref><ref id="brb3936-bib-0020"><mixed-citation publication-type="journal" id="brb3936-cit-0020">
<string-name>
<surname>Dursun</surname>, <given-names>E.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Gezen&#x02010;Ak</surname>, <given-names>D.</given-names>
</string-name> (<year>2017</year>). <article-title>Vitamin D receptor is present on the neuronal plasma membrane and is co&#x02010;localized with amyloid precursor protein, ADAM10 or Nicastrin</article-title>. <source>PLoS ONE</source>, <volume>12</volume>, <fpage>e0188605</fpage>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0188605">https://doi.org/10.1371/journal.pone.0188605</ext-link>
<pub-id pub-id-type="pmid">29176823</pub-id></mixed-citation></ref><ref id="brb3936-bib-0021"><mixed-citation publication-type="journal" id="brb3936-cit-0021">
<string-name>
<surname>Dursun</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<surname>Gezen&#x02010;Ak</surname>, <given-names>D.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Yilmazer</surname>, <given-names>S.</given-names>
</string-name> (<year>2010</year>). <article-title>A novel perspective for Alzheimer's Disease: Vitamin D receptor suppression by amyloid&#x02010;&#x003b2; and preventing the Amyloid&#x02010;&#x003b2; induced Alterations by Vitamin D in cortical neurons</article-title>. <source>Journal of Alzheimer's Disease</source>, <volume>23</volume>, <fpage>1</fpage>&#x02013;<lpage>13</lpage>.</mixed-citation></ref><ref id="brb3936-bib-0022"><mixed-citation publication-type="journal" id="brb3936-cit-0022">
<string-name>
<surname>Eastell</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>Yergey</surname>, <given-names>A. L.</given-names>
</string-name>, <string-name>
<surname>Vieira</surname>, <given-names>N. E.</given-names>
</string-name>, <string-name>
<surname>Cedel</surname>, <given-names>S. L.</given-names>
</string-name>, <string-name>
<surname>Kumar</surname>, <given-names>R.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Riggs</surname>, <given-names>B. L.</given-names>
</string-name> (<year>1991</year>). <article-title>Interrelationship among vitamin D metabolism, true calcium absorption, parathyroid function, and age in women: Evidence of an age&#x02010;related intestinal resistance to 1,25&#x02010;dihydroxyvitamin D action</article-title>. <source>Journal of Bone and Mineral Research</source>, <volume>6</volume>, <fpage>125</fpage>&#x02013;<lpage>132</lpage>.<pub-id pub-id-type="pmid">2028834</pub-id></mixed-citation></ref><ref id="brb3936-bib-0023"><mixed-citation publication-type="journal" id="brb3936-cit-0023">
<string-name>
<surname>Farid</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<surname>Volpe&#x02010;Gillot</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Petras</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Plou</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Caillat&#x02010;Vigneron</surname>, <given-names>N.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Blacher</surname>, <given-names>J.</given-names>
</string-name> (<year>2012</year>). <article-title>Correlation between serum 25&#x02010;hydroxyvitamin D concentrations and regional cerebral blood flow in degenerative dementia</article-title>. <source>Nuclear Medicine Communications</source>, <volume>33</volume>, <fpage>1048</fpage>&#x02013;<lpage>1052</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1097/MNM.0b013e32835674c4">https://doi.org/10.1097/MNM.0b013e32835674c4</ext-link>
<pub-id pub-id-type="pmid">22773150</pub-id></mixed-citation></ref><ref id="brb3936-bib-0024"><mixed-citation publication-type="journal" id="brb3936-cit-0024">
<string-name>
<surname>Feldman</surname>, <given-names>H. H.</given-names>
</string-name>, <string-name>
<surname>Van Baelen</surname>, <given-names>B.</given-names>
</string-name>, <string-name>
<surname>Kavanagh</surname>, <given-names>S. M.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Torfs</surname>, <given-names>K. E.</given-names>
</string-name> (<year>2005</year>). <article-title>Cognition, function, and caregiving time patterns in patients with mild&#x02010;to&#x02010;moderate Alzheimer disease: A 12&#x02010;month analysis</article-title>. <source>Alzheimer Disease &#x00026; Associated Disorders</source>, <volume>19</volume>, <fpage>29</fpage>&#x02013;<lpage>36</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1097/01.wad.0000157065.43282.bc">https://doi.org/10.1097/01.wad.0000157065.43282.bc</ext-link>
<pub-id pub-id-type="pmid">15764869</pub-id></mixed-citation></ref><ref id="brb3936-bib-0025"><mixed-citation publication-type="journal" id="brb3936-cit-0025">
<string-name>
<surname>Folstein</surname>, <given-names>M. F.</given-names>
</string-name>, <string-name>
<surname>Folstein</surname>, <given-names>S. E.</given-names>
</string-name>, &#x00026; <string-name>
<surname>McHugh</surname>, <given-names>P. R.</given-names>
</string-name> (<year>1975</year>). <article-title>&#x0201c;Mini&#x02010;mental state&#x0201d;. A practical method for grading the cognitive state of patients for the clinician</article-title>. <source>Journal of Psychiatric Research</source>, <volume>12</volume>, <fpage>189</fpage>&#x02013;<lpage>198</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/0022-3956(75)90026-6">https://doi.org/10.1016/0022-3956(75)90026-6</ext-link>
<pub-id pub-id-type="pmid">1202204</pub-id></mixed-citation></ref><ref id="brb3936-bib-0026"><mixed-citation publication-type="journal" id="brb3936-cit-0026">
<string-name>
<surname>Ganguli</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Snitz</surname>, <given-names>B. E.</given-names>
</string-name>, <string-name>
<surname>Saxton</surname>, <given-names>J. A.</given-names>
</string-name>, <string-name>
<surname>Chang</surname>, <given-names>C. C. H.</given-names>
</string-name>, <string-name>
<surname>Lee</surname>, <given-names>C. W.</given-names>
</string-name>, <string-name>
<surname>Vander Bilt</surname>, <given-names>J.</given-names>
</string-name>, &#x02026; <string-name>
<surname>Petersen</surname>, <given-names>R. C.</given-names>
</string-name> (<year>2011</year>). <article-title>Outcomes of mild cognitive impairment by definition: A population study</article-title>. <source>Archives of Neurology</source>, <volume>68</volume>, <fpage>761</fpage>&#x02013;<lpage>767</lpage>.<pub-id pub-id-type="pmid">21670400</pub-id></mixed-citation></ref><ref id="brb3936-bib-0027"><mixed-citation publication-type="journal" id="brb3936-cit-0027">
<string-name>
<surname>Gezen&#x02010;Ak</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<surname>Dursun</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<surname>Hana&#x0011f;as&#x00131;</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Bilgi&#x000e7;</surname>, <given-names>B.</given-names>
</string-name>, <string-name>
<surname>Lohman</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<surname>Araz</surname>, <given-names>&#x000d6;. S.</given-names>
</string-name>, &#x02026; <string-name>
<surname>Y&#x00131;lmazer</surname>, <given-names>S.</given-names>
</string-name> (<year>2013</year>). <article-title>BDNF, TNF&#x003b1;, HSP90, CFH, and IL&#x02010;10 serum levels in patients with early or late onset Alzheimer's disease or mild cognitive impairment</article-title>. <source>Journal of Alzheimers Disease</source>, <volume>37</volume>, <fpage>185</fpage>&#x02013;<lpage>195</lpage>.</mixed-citation></ref><ref id="brb3936-bib-0028"><mixed-citation publication-type="journal" id="brb3936-cit-0028">
<string-name>
<surname>Gezen&#x02010;AK</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<surname>Yilmazer</surname>, <given-names>S.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Dursun</surname>, <given-names>E.</given-names>
</string-name> (<year>2014</year>). <article-title>Why vitamin D in Alzheimer's disease? The hypothesis</article-title>. <source>Journal of Alzheimer's Disease</source>, <volume>40</volume>, <fpage>257</fpage>&#x02013;<lpage>269</lpage>.</mixed-citation></ref><ref id="brb3936-bib-0029"><mixed-citation publication-type="journal" id="brb3936-cit-0029">
<string-name>
<surname>Haglin</surname>, <given-names>L.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Backman</surname>, <given-names>L.</given-names>
</string-name> (<year>2016</year>). <article-title>Covariation between plasma phosphate and daytime cortisol in early Parkinson's disease</article-title>. <source>Brain and Behavior</source>, <volume>6</volume>, <fpage>e00556</fpage>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/brb3.556">https://doi.org/10.1002/brb3.556</ext-link>
<pub-id pub-id-type="pmid">28031994</pub-id></mixed-citation></ref><ref id="brb3936-bib-0030"><mixed-citation publication-type="journal" id="brb3936-cit-0030">
<string-name>
<surname>Halloran</surname>, <given-names>B. P.</given-names>
</string-name>, <string-name>
<surname>Portale</surname>, <given-names>A. A.</given-names>
</string-name>, <string-name>
<surname>Lonergan</surname>, <given-names>E. T.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Morris</surname>, <given-names>R. C.</given-names>
<suffix>Jr</suffix>
</string-name> (<year>1990</year>). <article-title>Production and metabolic clearance of 1,25&#x02010;dihydroxyvitamin D in men: Effect of advancing age</article-title>. <source>Journal of Clinical Endocrinology and Metabolism</source>, <volume>70</volume>, <fpage>318</fpage>&#x02013;<lpage>323</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1210/jcem-70-2-318">https://doi.org/10.1210/jcem-70-2-318</ext-link>
<pub-id pub-id-type="pmid">2298850</pub-id></mixed-citation></ref><ref id="brb3936-bib-0031"><mixed-citation publication-type="journal" id="brb3936-cit-0031">
<string-name>
<surname>Hansson</surname>, <given-names>O.</given-names>
</string-name>, <string-name>
<surname>Zetterberg</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Buchhave</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<surname>Londos</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<surname>Blennow</surname>, <given-names>K.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Minthon</surname>, <given-names>L.</given-names>
</string-name> (<year>2006</year>). <article-title>Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: A follow&#x02010;up study</article-title>. <source>Lancet Neurology</source>, <volume>5</volume>, <fpage>228</fpage>&#x02013;<lpage>234</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/S1474-4422(06)70355-6">https://doi.org/10.1016/S1474-4422(06)70355-6</ext-link>
<pub-id pub-id-type="pmid">16488378</pub-id></mixed-citation></ref><ref id="brb3936-bib-0032"><mixed-citation publication-type="journal" id="brb3936-cit-0032">
<string-name>
<surname>Harms</surname>, <given-names>L. R.</given-names>
</string-name>, <string-name>
<surname>Burne</surname>, <given-names>T. H. J.</given-names>
</string-name>, <string-name>
<surname>Eyles</surname>, <given-names>D. W.</given-names>
</string-name>, &#x00026; <string-name>
<surname>McGrath</surname>, <given-names>J. J.</given-names>
</string-name> (<year>2011</year>). <article-title>Vitamin D and the brain</article-title>. <source>Clinical Endocrinology &#x00026; Metabolism</source>, <volume>25</volume>, <fpage>657</fpage>&#x02013;<lpage>669</lpage>.<pub-id pub-id-type="pmid">21872806</pub-id></mixed-citation></ref><ref id="brb3936-bib-0033"><mixed-citation publication-type="journal" id="brb3936-cit-0033">
<string-name>
<surname>Hooshmand</surname>, <given-names>B.</given-names>
</string-name>, <string-name>
<surname>L&#x000f6;kk</surname>, <given-names>J.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Solomon</surname>, <given-names>A.</given-names>
</string-name> (<year>2014</year>). <article-title>Vitamin D in relation to cognitive impairment, cerebrospinal fluid biomarkers, and brain volumes</article-title>. <source>The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences</source>, <volume>69</volume>, <fpage>1132</fpage>&#x02013;<lpage>1138</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/gerona/glu022">https://doi.org/10.1093/gerona/glu022</ext-link>
</mixed-citation></ref><ref id="brb3936-bib-0034"><mixed-citation publication-type="journal" id="brb3936-cit-0034">
<string-name>
<surname>Jones</surname>, <given-names>G.</given-names>
</string-name>, <string-name>
<surname>Strugnell</surname>, <given-names>S. A.</given-names>
</string-name>, &#x00026; <string-name>
<surname>DeLuca</surname>, <given-names>H. F.</given-names>
</string-name> (<year>1998</year>). <article-title>Current understanding of the molecular actions of vitamin D</article-title>. <source>Physiological Reviews</source>, <volume>78</volume>, <fpage>1193</fpage>&#x02013;<lpage>1231</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1152/physrev.1998.78.4.1193">https://doi.org/10.1152/physrev.1998.78.4.1193</ext-link>
<pub-id pub-id-type="pmid">9790574</pub-id></mixed-citation></ref><ref id="brb3936-bib-0035"><mixed-citation publication-type="journal" id="brb3936-cit-0035">
<string-name>
<surname>Landel</surname>, <given-names>V.</given-names>
</string-name>, <string-name>
<surname>Annweiler</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Millet</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<surname>Morello</surname>, <given-names>M.</given-names>
</string-name>, &#x00026; <string-name>
<surname>F&#x000e9;ron</surname>, <given-names>F.</given-names>
</string-name> (<year>2016</year>). <article-title>Vitamin D, cognition and Alzheimer's Disease: The therapeutic benefit is in the D&#x02010;tails</article-title>. <source>Journal of Alzheimer's Disease</source>, <volume>53</volume>, <fpage>419</fpage>&#x02013;<lpage>444</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3233/JAD-150943">https://doi.org/10.3233/JAD-150943</ext-link>
</mixed-citation></ref><ref id="brb3936-bib-0036"><mixed-citation publication-type="journal" id="brb3936-cit-0036">
<string-name>
<surname>Lemire</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<surname>Brangier</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Beaudenon</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Duval</surname>, <given-names>G. T.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Annweiler</surname>, <given-names>C.</given-names>
</string-name> (<year>2016</year>). <article-title>Cognitive changes under memantine according to vitamin D status in Alzheimer patients: An exposed/unexposed cohort pilot study</article-title>. <source>The Journal of Steroid Biochemistry and Molecular Biology</source>, <volume>175</volume>, <fpage>151</fpage>&#x02013;<lpage>156</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.jsbmb.2016.12.019">https://doi.org/10.1016/j.jsbmb.2016.12.019</ext-link>
<pub-id pub-id-type="pmid">28042052</pub-id></mixed-citation></ref><ref id="brb3936-bib-0037"><mixed-citation publication-type="journal" id="brb3936-cit-0037">
<string-name>
<surname>Littlejohns</surname>, <given-names>T. J.</given-names>
</string-name>, <string-name>
<surname>Henley</surname>, <given-names>W. E.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Lang</surname>, <given-names>I. A.</given-names>
</string-name> (<year>2014</year>). <article-title>Vitamin D and the risk of dementia and Alzheimer disease</article-title>. <source>Neurology</source>, <volume>83</volume>, <fpage>920</fpage>&#x02013;<lpage>928</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1212/WNL.0000000000000755">https://doi.org/10.1212/WNL.0000000000000755</ext-link>
<pub-id pub-id-type="pmid">25098535</pub-id></mixed-citation></ref><ref id="brb3936-bib-0038"><mixed-citation publication-type="journal" id="brb3936-cit-0038">
<string-name>
<surname>Mark</surname>, <given-names>K. A.</given-names>
</string-name>, <string-name>
<surname>Dumas</surname>, <given-names>K. J.</given-names>
</string-name>, <string-name>
<surname>Bhaumik</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<surname>Schilling</surname>, <given-names>B.</given-names>
</string-name>, <string-name>
<surname>Davis</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Oron</surname>, <given-names>T. R.</given-names>
</string-name>, &#x02026; <string-name>
<surname>Ramanathan</surname>, <given-names>A.</given-names>
</string-name> (<year>2016</year>). <article-title>Protein homeostasis and longevity via the stress response pathway genes skn&#x02010;1, ire&#x02010;1, and xbp&#x02010;1</article-title>. <source>Cell Reports</source>, <volume>17</volume>, <fpage>1227</fpage>&#x02013;<lpage>1237</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.celrep.2016.09.086">https://doi.org/10.1016/j.celrep.2016.09.086</ext-link>
<pub-id pub-id-type="pmid">27783938</pub-id></mixed-citation></ref><ref id="brb3936-bib-0039"><mixed-citation publication-type="journal" id="brb3936-cit-0039">
<string-name>
<surname>Masoumi</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Goldenson</surname>, <given-names>B.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Ghirmai</surname>, <given-names>S.</given-names>
</string-name> (<year>2009</year>). <article-title>1alpha, 25&#x02010;dihydroxyvitamin D3 interacts with curcuminoids to stimulate amyloid&#x02010;beta clearance by macrophages of Alzheimer's disease patients</article-title>. <source>Journal of Alzheimer's Disease</source>, <volume>17</volume>, <fpage>703</fpage>&#x02013;<lpage>717</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3233/JAD-2009-1080">https://doi.org/10.3233/JAD-2009-1080</ext-link>
</mixed-citation></ref><ref id="brb3936-bib-0040"><mixed-citation publication-type="journal" id="brb3936-cit-0040">
<string-name>
<surname>Musicco</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Palmer</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<surname>Salamone</surname>, <given-names>G.</given-names>
</string-name>, <string-name>
<surname>Lupo</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>Perri</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>Mosti</surname>, <given-names>S.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Caltagirone</surname>, <given-names>C.</given-names>
</string-name> (<year>2009</year>). <article-title>Predictors of progression of cognitive decline in Alzheimer's disease: The role of vascular and sociodemographic factors</article-title>. <source>Journal of Neurology</source>, <volume>256</volume>, <fpage>1288</fpage>&#x02013;<lpage>1295</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s00415-009-5116-4">https://doi.org/10.1007/s00415-009-5116-4</ext-link>
<pub-id pub-id-type="pmid">19353221</pub-id></mixed-citation></ref><ref id="brb3936-bib-0041"><mixed-citation publication-type="journal" id="brb3936-cit-0041">
<string-name>
<surname>Nissou</surname>, <given-names>M. F.</given-names>
</string-name>, <string-name>
<surname>Guttin</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Zenga</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Berger</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>Issartel</surname>, <given-names>J. P.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Wion</surname>, <given-names>D.</given-names>
</string-name> (<year>2014</year>). <article-title>Additional clues for a protective role of vitamin D in neurodegenerative diseases:1,25&#x02010;dihydroxyvitamin D3 triggers an anti&#x02010;inflammatory response in brain pericytes</article-title>. <source>Journal of Alzheimer's Disease</source>, <volume>42</volume>, <fpage>789</fpage>&#x02013;<lpage>799</lpage>.</mixed-citation></ref><ref id="brb3936-bib-0042"><mixed-citation publication-type="journal" id="brb3936-cit-0042">
<string-name>
<surname>O'Bryant</surname>, <given-names>S. E.</given-names>
</string-name>, <string-name>
<surname>Humphreys</surname>, <given-names>J. D.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Smith</surname>, <given-names>G. E.</given-names>
</string-name> (<year>2008</year>). <article-title>Detecting dementia with the mini&#x02010;mental state examination in highly educated individuals</article-title>. <source>Archives of Neurology</source>, <volume>65</volume>, <fpage>963</fpage>&#x02013;<lpage>967</lpage>.<pub-id pub-id-type="pmid">18625866</pub-id></mixed-citation></ref><ref id="brb3936-bib-0043"><mixed-citation publication-type="journal" id="brb3936-cit-0043">
<string-name>
<surname>Palmqvist</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Hertze</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Minthon</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Wattmo</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Zetterberg</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Blennow</surname>, <given-names>K.</given-names>
</string-name>, &#x02026; <string-name>
<surname>Hansson</surname>, <given-names>O.</given-names>
</string-name> (<year>2012</year>). <article-title>Comparison of brief cognitive tests and CSF biomarkers in predicting Alzheimer's Disease in mild cognitive impairment: Six&#x02010;year follow&#x02010;up study</article-title>. <source>PLoS ONE</source>, <volume>7</volume>, <fpage>e38639</fpage>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0038639">https://doi.org/10.1371/journal.pone.0038639</ext-link>
<pub-id pub-id-type="pmid">22761691</pub-id></mixed-citation></ref><ref id="brb3936-bib-0044"><mixed-citation publication-type="journal" id="brb3936-cit-0044">
<string-name>
<surname>Petersen</surname>, <given-names>R. C.</given-names>
</string-name> (<year>2011</year>). <article-title>Clinical practice. Mild cognitive impairment</article-title>. <source>The New England Journal of Medicine</source>, <volume>364</volume>, <fpage>2227</fpage>&#x02013;<lpage>2234</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1056/NEJMcp0910237">https://doi.org/10.1056/NEJMcp0910237</ext-link>
<pub-id pub-id-type="pmid">21651394</pub-id></mixed-citation></ref><ref id="brb3936-bib-0045"><mixed-citation publication-type="journal" id="brb3936-cit-0045">
<string-name>
<surname>Petersen</surname>, <given-names>R. C.</given-names>
</string-name>, <string-name>
<surname>Doody</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>Kurz</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Mohs</surname>, <given-names>R. C.</given-names>
</string-name>, <string-name>
<surname>Morris</surname>, <given-names>J. C.</given-names>
</string-name>, <string-name>
<surname>Rabins</surname>, <given-names>P. V.</given-names>
</string-name>, &#x02026; <string-name>
<surname>Winblad</surname>, <given-names>B.</given-names>
</string-name> (<year>2001</year>). <article-title>Current concepts in mild cognitive impairment</article-title>. <source>Archives of Neurology</source>, <volume>58</volume>, <fpage>1985</fpage>&#x02013;<lpage>1992</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1001/archneur.58.12.1985">https://doi.org/10.1001/archneur.58.12.1985</ext-link>
<pub-id pub-id-type="pmid">11735772</pub-id></mixed-citation></ref><ref id="brb3936-bib-0046"><mixed-citation publication-type="journal" id="brb3936-cit-0046">
<string-name>
<surname>Querfurth</surname>, <given-names>H. W.</given-names>
</string-name>, &#x00026; <string-name>
<surname>LaFerla</surname>, <given-names>F. M.</given-names>
</string-name> (<year>2010</year>). <article-title>Alzheimer's disease</article-title>. <source>The New England Journal of Medicine</source>, <volume>362</volume>, <fpage>329</fpage>&#x02013;<lpage>344</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1056/NEJMra0909142">https://doi.org/10.1056/NEJMra0909142</ext-link>
<pub-id pub-id-type="pmid">20107219</pub-id></mixed-citation></ref><ref id="brb3936-bib-0047"><mixed-citation publication-type="journal" id="brb3936-cit-0047">
<string-name>
<surname>Ritchie</surname>, <given-names>K.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Touchon</surname>, <given-names>J.</given-names>
</string-name> (<year>2000</year>). <article-title>Mild cognitive impairment: Conceptual basis and current nosological status</article-title>. <source>Lancet</source>, <volume>355</volume>, <fpage>225</fpage>&#x02013;<lpage>228</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/S0140-6736(99)06155-3">https://doi.org/10.1016/S0140-6736(99)06155-3</ext-link>
<pub-id pub-id-type="pmid">10675135</pub-id></mixed-citation></ref><ref id="brb3936-bib-0048"><mixed-citation publication-type="journal" id="brb3936-cit-0048">
<string-name>
<surname>Schl&#x000f6;gl</surname>, <given-names>M.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Holick</surname>, <given-names>M. F.</given-names>
</string-name> (<year>2014</year>). <article-title>Vitamin D and neurocognitive function</article-title>. <source>Clinical Interventions in Aging</source>, <volume>9</volume>, <fpage>559</fpage>&#x02013;<lpage>568</lpage>.<pub-id pub-id-type="pmid">24729696</pub-id></mixed-citation></ref><ref id="brb3936-bib-0049"><mixed-citation publication-type="journal" id="brb3936-cit-0049">
<string-name>
<surname>Silverman</surname>, <given-names>D. H.</given-names>
</string-name>, <string-name>
<surname>Small</surname>, <given-names>G. W.</given-names>
</string-name>, <string-name>
<surname>Chang</surname>, <given-names>C. Y.</given-names>
</string-name>, <string-name>
<surname>Lu</surname>, <given-names>C. S.</given-names>
</string-name>, <string-name>
<surname>de Aburto</surname>, <given-names>M. A. K.</given-names>
</string-name>, <string-name>
<surname>Chen</surname>, <given-names>W.</given-names>
</string-name>, &#x02026; <string-name>
<surname>Schapiro</surname>, <given-names>M. B.</given-names>
</string-name> (<year>2001</year>). <article-title>Positron emission tomography in evaluation of dementia: Regional brain metabolism and long&#x02010;term outcome</article-title>. <source>The Journal of the American Medical Association</source>, <volume>286</volume>, <fpage>2120</fpage>&#x02013;<lpage>2127</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1001/jama.286.17.2120">https://doi.org/10.1001/jama.286.17.2120</ext-link>
<pub-id pub-id-type="pmid">11694153</pub-id></mixed-citation></ref><ref id="brb3936-bib-0050"><mixed-citation publication-type="journal" id="brb3936-cit-0050">
<string-name>
<surname>Small</surname>, <given-names>G. W.</given-names>
</string-name>, <string-name>
<surname>Kepe</surname>, <given-names>V.</given-names>
</string-name>, <string-name>
<surname>Ercoli</surname>, <given-names>L. M.</given-names>
</string-name>, <string-name>
<surname>Siddarth</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<surname>Bookheimer</surname>, <given-names>S. Y.</given-names>
</string-name>, <string-name>
<surname>Miller</surname>, <given-names>K. J.</given-names>
</string-name>, &#x02026; <string-name>
<surname>Thompson</surname>, <given-names>P. M.</given-names>
</string-name> (<year>2006</year>). <article-title>PET of brain amyloid and tau in mild cognitive impairment</article-title>. <source>The New England Journal of Medicine</source>, <volume>355</volume>, <fpage>2652</fpage>&#x02013;<lpage>2663</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1056/NEJMoa054625">https://doi.org/10.1056/NEJMoa054625</ext-link>
<pub-id pub-id-type="pmid">17182990</pub-id></mixed-citation></ref><ref id="brb3936-bib-0051"><mixed-citation publication-type="journal" id="brb3936-cit-0051">
<string-name>
<surname>Sunderland</surname>, <given-names>T.</given-names>
</string-name>, <string-name>
<surname>Linker</surname>, <given-names>G.</given-names>
</string-name>, <string-name>
<surname>Mirza</surname>, <given-names>N.</given-names>
</string-name>, <string-name>
<surname>Putnam</surname>, <given-names>K. T.</given-names>
</string-name>, <string-name>
<surname>Friedman</surname>, <given-names>D. L.</given-names>
</string-name>, <string-name>
<surname>Kimmel</surname>, <given-names>L. H.</given-names>
</string-name>, &#x02026; <string-name>
<surname>Bartko</surname>, <given-names>J. J.</given-names>
</string-name> (<year>2003</year>). <article-title>Decreased beta&#x02010;amyloid1&#x02010;42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease</article-title>. <source>The Journal of the American Medical Association</source>, <volume>289</volume>, <fpage>2094</fpage>&#x02013;<lpage>2103</lpage>.<pub-id pub-id-type="pmid">12709467</pub-id></mixed-citation></ref><ref id="brb3936-bib-0052"><mixed-citation publication-type="journal" id="brb3936-cit-0052">
<string-name>
<surname>Votruba</surname>, <given-names>K. L.</given-names>
</string-name>, <string-name>
<surname>Persad</surname>, <given-names>C.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Giordani</surname>, <given-names>B.</given-names>
</string-name> (<year>2016</year>). <article-title>Cognitive deficits in healthy elderly population with &#x0201c;normal&#x0201d; scores on the mini&#x02010;mental state examination</article-title>. <source>Journal of Geriatric Psychiatry and Neurology</source>, <volume>29</volume>, <fpage>126</fpage>&#x02013;<lpage>132</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1177/0891988716629858">https://doi.org/10.1177/0891988716629858</ext-link>
<pub-id pub-id-type="pmid">26850856</pub-id></mixed-citation></ref><ref id="brb3936-bib-0053"><mixed-citation publication-type="journal" id="brb3936-cit-0053">
<string-name>
<surname>Yin</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Fan</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Lin</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>Xu</surname>, <given-names>Y.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Zhang</surname>, <given-names>J.</given-names>
</string-name> (<year>2015</year>). <article-title>Nutrient biomarkers and vascular risk factors in stages of mild cognitive impairment: A cross&#x02010;sectional study</article-title>. <source>The Journal of Nutrition Health and Aging</source>, <volume>19</volume>, <fpage>39</fpage>&#x02013;<lpage>47</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s12603-014-0510-8">https://doi.org/10.1007/s12603-014-0510-8</ext-link>
</mixed-citation></ref><ref id="brb3936-bib-0054"><mixed-citation publication-type="journal" id="brb3936-cit-0054">
<string-name>
<surname>Yu</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Gattoni&#x02010;Celli</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Zhu</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Bhat</surname>, <given-names>N. R.</given-names>
</string-name>, <string-name>
<surname>Sambamurti</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<surname>Gattoni&#x02010;Celli</surname>, <given-names>S.</given-names>
</string-name>, &#x02026; <string-name>
<surname>Kindy</surname>, <given-names>M. S.</given-names>
</string-name> (<year>2011</year>). <article-title>Vitamin D3&#x02010;enriched diet correlates with a decrease of amyloid plaques in the brain of A&#x003b2;PP transgenic mice</article-title>. <source>Journal of Alzheimer's Disease</source>, <volume>25</volume>, <fpage>295</fpage>&#x02013;<lpage>307</lpage>.</mixed-citation></ref></ref-list></back></article>